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ABSTRACT  
 This study evaluated the potential toxicity, genotoxicity, and cellular uptake of 
various sizes and concentrations of chitosan (CS) nanoparticles cultured with 
normal human dental pulp cells. Normal human dental pulp cells (hDPCs) were 
derived from human dental pulp tissues and cultured with (50–67) nm and (318–
350) nm CS-nanoparticles in concentrations of 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 
mg/mL, and 4 mg/mL as study groups and 0 mg/mL as a control group for time 
intervals of 16 hours, 24 hours, 3 days, 7 days and 14 days. Attachment efficiency 
and proliferation rate were assessed by measuring the optical density of crystal 
violet-stained cells. Cell viability was determined by the activity of mitochondrial 
dehydrogenase enzymes. Genotoxicity was assessed using the cytokinesis-block 
micronucleus method and by measuring the fluorescent intensity of phosphorylated 
H2AX nuclear foci. Cellular uptake was determined by tagging chitosan 
nanoparticles with FITC stain and then measuring the fluorescence intensity of 
vi 
 
FITC-tagged chitosan nanoparticles using a spectrophotometer. Statistical analysis 
was performed using chi-square, one-way ANOVA, and post-hoc Tukey tests.  
All concentrations of the (50–67) nm group significantly reduced attachment 
efficiency in comparison with control (P< 0.01) and with (318–350) nm group 
(p<0.01). Proliferation rate and cell viability were significantly reduced in cells 
exposed to various concentrations of (50-67) nm chitosan when compared to (318-
350) nm group (P<0.05) and control group (P<0.05). For both size groups, higher 
concentrations significantly showed lower proliferation rate and cell viability when 
compared to lower concentration (P< 0.01). CS-nanoparticles were able to 
internalize hDPCs and significantly induced micronuclei, nuclear buds, and pH2AX 
at concentrations of 0.5 mg/mL and 2 mg/mL as compared to 0.1 mg/mL (P<0.01) 
and control groups (P< 0.01). At both the 0.5 mg/mL and 2 mg/mL concentrations, 
(50–67) nm chitosan significantly induced higher proportions of micronuclei (P= 
0.001), nuclear buds (P= 0.009), and pH2AX nuclear foci (P= 0.00004) compared to 
(318–350) nm chitosan. In conclusion, CS-nanoparticles at sizes (50–67) nm and 
(318–350) nm at a concentration of (0.5–4) mg/mL internalized hDPCs and 
exhibited cytotoxic and genotoxic effects in dose-dependent and size-associated 
manners. 
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Chapter 1: INTRODUCTION 
 
 
1.1 Nanotoxicity of metallic, inorganic, and organic nanoparticles 
 
      As nanotechnology implementation in the biomedical field advances, numerous studies 
have focused on the molecular biocompatibility of various sizes, concentrations, and types of 
nanoparticles on different cell cultures. For example, the literature features extensive 
investigations of the biocompatibility of metallic nanoparticles, such as silver nanoparticles 
(1). There are a number of publications available describing both in vitro and in vivo silver 
nanoparticle toxicity (2, 3). Results have shown that the cytotoxic and genotoxic effects of 
silver nanoparticles are dependent on nanoparticle concentration, size, exposure time, and 
environmental factors. The proposed mechanism of apoptosis and the inhibition of cell 
proliferation caused by silver nanoparticles might be understood as the interaction between 
the nanoparticles and cell membrane proteins that eventually leads to an increased production 
of reactive oxygen species (4). It has been reported that 10 to 100 nm silver nanoparticles are 
highly toxic at lower concentrations ranging from 5 to 10 micrograms per milliliter (5, 6). 
Haase et al. reported that the cytotoxicity of silver nanoparticles was mainly induced through 
the mitochondrial pathway by reducing glutathione (GSH), high lipid peroxidation, and 
reactive oxygen species-responsive genes that cause DNA damage, apoptosis, and necrosis 
(4). Furthermore, several in vivo studies have shown that silver nanoparticles cause adverse 
effects on reproduction, malformations, and morphological deformities in different non-





      On the other hand, some in vitro studies have shown an analogous cytotoxic and 
genotoxic effect induced by inorganic nanoparticles, such as silica nanoparticles. Park et al. 
reported that culturing two different sizes of silica nanoparticles, 30 nm and 80 nm, with 
mouse embryonic fibroblasts induced a genotoxic effect (8). The biocompatibility of silica 
nanoparticles was also tested on cells derived from humans. A study published by Lin et al. 
showed similar cytotoxic effects and reduction of cell viability when 15 nm and 46 nm silica 
nanoparticles at a concentration of 10 micrograms per millimeter were cultured with human 
lung cancer cells for 48 and 72 h (9). Moreover, Chou et al. explained the mechanism of 
genotoxicity induced by silica nanoparticles on an HFL-1 cell culture (10). Chou reported an 
increase in production of reactive oxygen species by HFL-1 cells after exposure to different 
concentrations of 20 nm and 80 nm silica nanoparticles (10). Additionally, in the same study, 
it was shown that silica nanoparticles further induced p53, increased expression of Bax genes, 
inhibited cl-2, and activated caspase 9 genes, which consequently led to apoptosis of HFL-1 
cells (10). Another study performed on rodent cells showed that silica nanoparticles play a 
role in inducing the production proinflammatory cytokines like interleukin-1 and significantly 
decreased the viability of rodent cells (11).  
      The focus has been shifted to use nanoparticles prepared from natural and organic sources 
to be applied in biomedical experiments. Chitosan is a common example of organic 
nanoparticles and has been tested in numerous studies. Despite the promising features of 
chitosan nanoparticles, a cytotoxic effect induced by chitosan nanoparticles on various cell 
cultures was previously reported in animal models. In Park et al.’s study, 100 nm chitosan 
nanoparticles showed an inhibitory antiproliferative effect on embryonic mice cells in a dose-




In Park et al.’s study, there was upregulation in apoptotic proteins such as Bad and Bax as the 
concentration of chitosan nanoparticles increased from 0.01 mg/mL to 0.2 mg/mL (12). In 
another study conducted on a zebrafish model, cells that were exposed to 250 nm chitosan 
nanoparticles showed variable mortality rates at different nanoparticle concentrations (13). A 
mortality rate of nearly 100% was achieved at a concentration of 0.05 mg/mL, while a 
mortality rate of less than 20% was observed with a concentration of 0.005 mg/mL (13). 
Furthermore, a paper by Almalik et al. showed a significant release of lactate dehydrogenase 
enzymes, production of reactive oxygen species, and a reduction in cell viability in a Chinese 
hamster ovary cell culture exposed to 222 nm chitosan nanoparticles at a dose of 2.5 mg/mL 
for 24 h (14). It is crucial to note that most cytotoxic evaluations of chitosan nanoparticles 
were conducted on cells that are sensitive in microenvironments, which might exaggerate the 
results. However, it is still imperative to evaluate the biocompatibility of chitosan 
nanoparticles on dental pulp cells prior to any clinical trials.  
 
1.2 Chitin and Chitosan: Chemical and Biological Properties 
      The human body and living organisms consist of four major biomolecules, including 
polysaccharides, proteins, lipids, and nucleic acids. Polysaccharides are plentiful and 
considered essential to living because polysaccharides play an important role in biological 
processes such as energy and structural transportation (15). Different types of 
polysaccharides exist, and the variety of types depends on molecular sequences, 
configuration of linkages between monosaccharides, ring size, and the presence of any 
substituents (16). Chain conformation and intermolecular associations can impact the 
physiochemical properties of polysaccharides (16). For example, polysaccharides that contain 
many hydroxyl groups are known to manifest a hydrophilic feature (17). Some of the 
recognized types of polysaccharides include starch, glucose, cellulose, and chitin. 
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1.2.1: Chitin structure, source, and properties 
      Chitin is found naturally within the exoskeletons of crustaceans (such as shrimps, lobster, 
krill, crabs, squids, or crawfishes), insect cuticles, marine diatoms, and fungal cell walls (18). 
Chemically, the internal structure of chitin consists of N-acetyl-D-glucosamine, which is 
linearly linked together by -(1-4) glycosidic bonds (19). Interestingly, the chemical 
composition of chitin resembles the structure of cellulose except that cellulose contains aceto-
amide groups (-NHCOCH3) in the C2 position rather than a hydroxyl group (-OH) (19). 
Chitin has different biological properties based on the resource, and these properties 
determine chitin’s application. Chitins which are derived from shrimp shells can be useful in 
the food production industry (e.g. in food canning) (20), while chitins obtained from fungal 
walls have been reported to be useful in the process of food fermentation (20).  
 
      To extract chitin from crustaceans’ shells, shells should undergo two processes, namely 
deproteinization and demineralization, to dispose of the proteins and calcium carbonate 
present at a high concentration in the shells (21, 22). In the biomedical field, chitin has not 
been applied widely due to its poor solubility (23). Therefore, many studies have been 
conducted to modify the chemical structure of chitin to produce a superior molecule for 
biomedical applications. There are numerous derivatives that can be gained from chitin; 









 1.2.2: Chitosan structure, source, and properties 
 
      Chitosan is a poly-cationic polysaccharide that was first discovered by Rouget in 1859 
(24). It is derived from chitin through a chemical process called deacetylation (24). During 
this process, chitin is boiled in an alkaline solution (40–50% sodium hydroxide at 120 °C) for 
several hours (25). The purpose of this procedure is to discard acetyl groups from chitin in 
order to engender chitosan; nevertheless, this process has never been complete, which results 
in partially deacetyl chitosan (26). In addition to extracting chitosan form chitin, pure 
chitosan can be obtained via alternative sources because chitosan exists within the cell walls 
of some fungi (such as zygomycetes, green algae cherella species, and aspergillus niger), 
yeast, protozoa, and insect cuticles (27, 28). The chemical structure of chitosan varies based 
on its source. Some studies suggest that, in contrast to chitosan molecules obtained by the 
chitin deacetylation process which has uniform distribution of the acetyl groups along 
molecule chains, cultivation of aspergillus niger can produce chitosan with clusters of acetyl 
group residues (29). 
 
      Structurally, chitosan contains two units: deacetyl (D-glucoseamide) and acetyl (N-acetyl-
D-glucoseamide) (30). The proportion of the deacetyl unit within the chitosan molecule can 
be referred as a degree of deacetylation; this proportion varies considerably, resulting in a 
range of different kinds of chitosan with distinct features (26). Chitosan contains variable 
amounts (5–8%) of nitrogen within the amino groups, which are influenced by the degree of 
deacetylation that the molecule possesses (31). Unlike other types of polysaccharides that are 
neutral or acidic in nature, such as cellulose, dextran, pectin, alginic acid, agar, and agarose, 




      The physicochemical properties of chitosan are affected by multiple factors, including 
purity, molecular weight, chain length, degree of deacetylation, charge densities, and water 
retention values (32). These factors influence the properties of chitosan differently, allowing 
chitosan to be widely utilized for several applications. Chitosan exists in different molecular 
weights, and the variability of molecular weights is attributed to various factors during 
chitosan preparation, such as preparation time, temperature, and the starting concentration of 
chitosan (29). In this context, the average range of molecular weight varies broadly from 
hundreds to a million Dalton (33). The determination of the molecular weight of chitosan is 
important because it has a crucial impact on producing chitosan with different features (29). 
Many means can be used to accurately determine molecular weight, including light scattering 
spectrophotometry, gel permeation chromatography, and viscometry (25). 
 
      Another factor that can manipulate the chemical properties of chitosan is the degree of 
deacetylation. The degree of deacetylation can be defined as the ratio of acetyl to deacetyl 
units within the chitosan molecule (26). During chemical preparation, chitosan can be formed 
with different degrees of acetylation depending on the time of the treatment (26). Increasing 
treatment time leads to chitosan with a high degree of deacetylation (34). Furthermore, the 
ability of chitosan to absorb moisture, distribution of charges along the chain, viscosity, and 
solubility are influenced significantly by the degree of deacetylation (28, 34–36). Therefore, 
determination of the degree of deacetylation becomes necessary as it plays a role in 
manipulating the interior structure of the chitosan. Various equipment is available to 
precisely define these values, including FTIR, UV spectroscopy, H-NMR, C-solid, NMR 




      Solubility is one of the main features that distinguishes chitin from chitosan as chitosan 
cannot be dissolved either in water or in organic solvents yet shows reasonable solubility in 
diluted aqueous acids such as 0.1 M acetic acid (23, 37). Accordingly, chitin can be 
transformed from being insoluble into an acid-soluble chitosan (23). Chitosan solubility has 
been proven to be pH-dependent due to the presence of active amino groups (-NH2) within 
chitosan molecules (38). Given the background, once chitosan is dissolved in a solution that 
possesses a pH of 6 or below, amino groups are protonated and become more positively 
charged cationic amine groups within chitosan (23, 38). Consequently, this enhances the 
intermolecular electric repulsion within the chitosan molecule, resulting in a polycationic 
soluble polysaccharide (23, 38) 
 
      Conversely, when the pH surpasses 6, chitosan tends to lose more ionic charges and 
therefore precipitates in the solution due to deprotonation of the amine groups, which 
explains the insolubility of chitosan in an alkaline medium (28, 39). This solubility is one of 
the features that makes chitosan more advantageous molecule than chitin; after dissolution, 
chitosan can be formed into numerous states such as gels, beads, membranes, sponges, films, 










      Furthermore, chitosan possesses variable degrees of viscosity, ranging from 10 to 1000 
mPa.s (40). Chitosan solutions are capable of having pseudoplastic or viscoelastic properties 
to act as thickeners, stabilizers, or suspending agents, but these properties are influenced 
mainly by the degree of deacetylation as well as by molecular weight (41). 
 
      In addition to the solubility features, chitosan is considered superior to chitin because 
chitosan has numerous reactive functional groups (e.g. amino groups) in the C2 position, in 
addition to primary and secondary hydroxyl groups in the C3 and C6 positions, respectively 
(28). Such reactive groups can be undergone under mild conditions through a process called 
chemical derivatization, which manipulates the physiochemical properties of chitosan and 
results in better solubility at a neutral pH (28).  
 
      Moreover, chitosan can be conjugated within certain drugs and complex agents like 
ethylenediamine tetra-acetic acid (EDTA) when amino groups exist freely within chitosan’s 
composition. Additionally, chitosan can express a muco-adhesive property when prepared in 
a media with a pH below 6.5 (42–45). On the other hand, a high percentage of nitrogen 
within chitosan improves chitosan’s ability to bind with transition metals, such as iron or 








      Biologically, chitosan has attracted more attention because of properties including 
biodegradation and antimicrobial effects. Chitosan is a stable molecule for a long period of 
time. However, under certain circumstances, it might be necessary to degrade chitosan from a 
large molecule into smaller oligomers to be exploited in variable applications (32). 
Chitosan’s degradation can be achieved in various ways, including chemical degradation (by 
acid hydrolysis or oxidative reductive degradation), radiation, or by using certain enzymes 
(46). There are claims that enzymatic degradation can be considered superior to other 
approaches because enzymatic degradation provides better control of the reaction by 
manipulating pH, temperature, and degradation time (39). Chitosan can be naturally degraded 
by enzymes such as lysosomes (which are present in saliva, blood, tears, and milk), chitinase, 
cellulose, hemicellulose protease, lipase, and chitonase (47–49). 
  
     As reported in the literature, chitosanase is proven to attack chitosan exclusively, whereas 
chitin is not affected by this enzyme (47,50). Chitosanase tends to catalyze endo-hydrolysis 
of the -(1-4) glycosidic linkage among the acetyl and deacetyl units of chitosan (47,50). 
Fukamizo et al. suggested that based on the action mechanism, chitosanase can be classified 
into three classes: Class 1, in which the enzyme attacks the linkage between D-glucosamine 
(deacetyl unit) and N-acetyl-D-glucoseamine (acetyl unit); Class 2, which is attributed to the 
chitosanase when it breaks the link between two deacetyl units (i.e. two D-glucosamines); 
and Class 3, which refers to the enzyme that is able to cleave both cases, either between two 
deacetyl units or between one deacetyl and another acetyl unit (51–53).  
 
      Any substance should demonstrate reasonable biocompatibility and safety when it is 
applied against living tissues. Biocompatibility means that any material should neither 
express any side effects locally or systemically nor be negatively impacted by the host’s 
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immune system. Although chitosan has been implemented extensively in the medical field, 
chitosan’s safety has been heavily debated. Takna et al.’s study reported that the uptake of 
chitosan either orally or parentally led to a significant reduction in the weights of mice, which 
led chitosan’s safety to be questioned (54). Moreover, it was claimed that chitosan expresses 
a cytotoxic effect on different cell cultures, including liver cells, brain neurons, and 
embryonic kidney cells. Additionally, many studies cite chitosan as responsible for blocking 
the effects of certain medicines, reducing the absorption of minerals, and reducing fat-soluble 
vitamins (55). Furthermore, regardless of the biological features of chitosan that make this 
molecule a promising material for certain applications, there is still a lack of studies 
evaluating the carcinogenic potential of chitosan in the form of macro, micro, or nano 
molecules. 
 
      All in all, chitosan possesses promising features in terms of biodegradation, antibacterial 
effects, and solubility, but chitosan’s biocompatibility remains controversial. When chitosan 
is to be implemented in different applications, many factors should be considered. These 
factors include pH, degree of deacetylation, concentration, molecular weights, purity, 
degradation approach, and size of the molecule’s particles. Familiarization with these factors 
can lead to better utilization of chitosan in various fields. Additionally, chitosan’s 










1.3 Biomedical Applications of Chitosan 
      Chitosan possesses several biological properties that have attracted attention in the 
biomedical field, such as mucoadhesive, hem-compatible, biodegradable, antitumor, 
antioxidant, and antimicrobial properties. 
 
1.3.1 Antibacterial agents 
      Studies have shown that chitosan exhibits antimicrobial activity against a wide range of 
bacteria. This property is attributed to the interaction between cationic chitosan and the 
negatively charged membrane of bacteria (56). In addition to surface charges, the hydrophilic 
property of bacterial cell walls enhances the interaction between nanoparticles and 
microorganisms more significantly than in mammalian cells (57). This interaction can alter 
the permeability of the cellular membrane of bacteria, resulting in the leakage of essential 
cellular components and consequently leading to cellular death (57). There are several factors 
that might influence chitosan nanoparticles surface charges and that would therefore affect 
the antimicrobial activity of chitosan. These factors include molecular weight, degree of 
deacetylation, the pH of the solution, and the role of cells (58). Researchers have exploited 
the antimicrobial property of chitosan to develop an effective insecticide against parasites and 
fungi that might invade warm-blooded animals. Common insecticides are usually made in the 
form of a spray to be spread on objects to reduce microbes, but factors like rain and wind can 
deplete the antimicrobial effect of insecticides over time. The chitosan macromolecule was 
developed as a sprayed insecticide that can prolong antimicrobial effects against rain and 





A study by Lanctot et al. explored different manipulations of chitosan’s antimicrobial activity 
to prevent the microbial infection of breastmilk in breast cancer patients (60). The short-term 
action of antibiotics and antibiotic resistance represent some drawbacks to using antibiotics to 
prevent microbial infection in breast cancer patients. For that reason, Lanctot et al. developed 
a chitosan hydrogel that can be injected into the teat of mammals to prevent the microbial 
infection of breastmilk (60). The results of Lanctot et al.’s study indicated that chitosan 
hydrogel resulted in the significant degradation of pathogens in the breast (60). This finding 
was attributed to the ability of the chitosan hydrogel to degrade galactophore and its 
activation of the immune response, which combats active microbial infections (60). 
 
1.3.2 Drug delivery system 
      Chitosan molecules’ ability to adhere to mucosal surfaces is another biological property 
that draws attention in the biomedical field. Many studies have been conducted to exploit the 
mucosal adhesivity of chitosan in drug delivery applications. The delivery of anticancer drugs 
via chitosan nanoparticles has also been investigated. Doxorubicin, which is commonly used 
for cancer treatment, has known side effects on patients, including cardiotoxicity (61). For 
this reason, some studies have tested the encapsulation of doxorubicin on chitosan 
nanoparticles to be delivered to targeted tissues. It was shown that chitosan nanoparticles 
significantly increase the absorption of doxorubicin from 1.8% to 38.74% in the whole small 
intestine (62). This finding suggests that the survival time—and thus the efficacy—of 
doxorubicin loaded into chitosan is increased when compared to doxorubicin without 





 Additionally, the performance of protein-based drugs such as insulin were improved when 
conjugated with chitosan nanoparticles (63). Enzyme degradation of protein-based drugs is a 
commonly reported drawback and reduces the efficacy of protein-based drugs. A study 
conducted by Sinha et al. demonstrated not only improved stability of protein-based drugs 
when encapsulated into chitosan nanoparticles but also showed a steady, controlled release of 
insulin over time that enhances the drug’s performance (63).  
 
      In addition to anticancer and protein-based drugs, gene encapsulation into chitosan 
nanoparticles has been shown to promote immune response (64). Akbuga et al. investigated 
chitosan nanoparticles loaded with IL-2 expression plasmids for gene-based immune therapy 
(65). Their results showed that the plasmids remained unchanged during encapsulation. High 
levels of chitosan nanoparticles loaded with IL-2 expression plasmids were obtained and 
showed similar production of IL-2 liposomes (65). The molecular weight and mass quantity 
of chitosan affects IL-2-producing cells in vitro. Two different DNA plasmids (pGL2 and 
pMK3) encapsulated in chitosan nanoparticles remained unchanged both in structure and 
function (65). 
 
      Moreover, as a result of the mucoadhesive and osmotic properties of chitosan, chitosan 
can greatly enhance the adsorption and transportation of peptides across nasal epithelium 
(35). Numerous studies have shown that chitosan can promote the transportation of 
macromolecules across mucosal barriers and interacts with nasal tissue (66). Additionally, 
chitosan microspheres can greatly improve systemic and local immune responses to 





1.3.3 Wound healing 
     Several studies have also indicated that chitosan has a significant role in wound healing 
(68). Chitosan’s promotion of wound healing can be attributed to the electrostatic interaction 
between platelets and the active amino groups that chitosan contains (69). Such interaction 
results in coagulation and therefore accelerates wound healing (69). Chitosan as a hemostatic 
agent possesses several properties, such as chemoattraction, activation of macrophages and 
neutrophils, acceleration of granulation tissue and re-epithelization, limited scar formation 
and contraction, analgesic properties, haemostasias, and intrinsic antibacterial properties (70–
72). 
 
1.4 Dental Applications of Chitosan 
1.4.1 Chitosan in oral hygiene products 
      Chitosan nanoparticles have been employed to improve the antibacterial activity of 
toothpastes, dentifrice, and mouthwashes. Recently, attention was drawn to natural means of 
improving oral hygiene products because natural products pose fewer side effects. Studies 
have shown that the incorporation of chitosan nanoparticles into sodium fluoride toothpaste 
can significantly boost and sustain antibacterial effects against a broad range of 
microorganisms (73). Carvalho and Lussi revealed that chitosan-fluoride-stannous toothpaste 
resulted in less tooth loss during the initial stages of enamel demineralization, a finding 
confirmed using scanning electron microscopes and dispersive x-ray spectroscopy (73). 
Chitosan’s ability to reduce enamel demineralization can be attributed to the electrostatic 
interaction between polycationic chitosan and the negatively charged surface of enamel (74). 
This interaction forms a protective layer on enamel that results in more resistance to acid 
byproducts released by microorganisms (74). The protective layer of chitosan on the 
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enamel’s surface can prevent planktonic bacterial adherence, which is a critical step in 
biofilm formation (74).  
 
      A study by Aliasghari et al. showed that chitosan nanoparticles significantly reduced 
streptococcus mutants’ adherence to enamel surface by 93%, reflecting chitosan 
nanoparticles’ potential as an anti-cariogenic agent (75). Furthermore, Costa et al. reported 
that 30 minutes of rinsing with a chitosan nanoparticle mouthwash resulted in significant 
reduction in the adherence of Enterococcus faecalis, S. mutans, Candida albicans, and 
Prevotella intermedia, which indicates that chitosan is a potential agent for treating dental 
caries, periodontitis, and candidiasis (76,77).  
 
1.4.2 Chitosan in restorative dentistry 
      In restorative dentistry, chitosan nanoparticles have been employed to improve the 
mechanical properties of restorative materials such as glass ionomers. Reported major 
drawbacks of glass ionomer as a bulk-filled restoration include insufficient fracture toughness 
and flexural strength (78, 79). The role of chitosan as a biocompatible polysaccharide that 
enhances the mechanical properties of glass ionomer cement (GIC) has been the subject of 
several studies. Petri et al. suggested that the addition of chitosan to glass ionomer resulted in 
significant improvement of flexural strength and increased the level of fluoride ions leached 
from GIC restoration (80). Moreover, GIC containing chitosan did not display any significant 
alterations in microleakage when compared to conventional GIC (81). The facilitating role of 
chitosan in enhancing the protein release profile when added to GICs is attributed to the 
formation of polymer complex phases resulting from the interaction of chitosan with 




1.4.3 Chitosan and osteointegration 
      The role of chitosan nanoparticles in implant coating to enhance osteointegration has been 
evaluated in several studies (82). Chitosan coating may affect the implant and bone interface 
area by altering biological, mechanical, and morphological properties. For example, in 
relation to mechanical properties, a chitosan coating changes the elastic modulus, thereby 
reducing any mismatch between the implant surface and the alveolar bone and reducing the 
areas of stress concentration (83). Moreover, chitosan coatings can be used to carry various 
medicaments such as antibiotics for localized delivery around the implant area. However, 
further research is required to validate whether such coatings are effective in inhibiting 
infection and promoting osseointegration (84). 
 
1.4.4 Chitosan and tissue engineering 
      Implantation of chitosan in guided tissue regeneration (GTR) to restore various 
periodontal defects has been investigated in the literature. The underlying strategy in GTR 
involves isolating the periodontal defect with a suitable membrane (resorbable or non-
resorbable) that acts as a physical impediment to gingival tissue infiltration into the osseous 
defects, thereby both encouraging bone regeneration and preventing space for fibrous tissue 
proliferation (85). There are several properties the membrane must have to be utilized for 
guided tissue regeneration, including the ability of the membrane to stabilize the wound, 
maintain the space, and impede unwanted gingival connective tissue and epithelium from 
getting into the bone defect (86, 87). All published studies that used a chitosan membrane in 
guided tissue regeneration used animals, but the findings of these studies suggested potential 




      Yeo et al. compared the efficacy of the chitosan membrane and Biomesh membrane, 
which is commonly used in clinical practice and contains polylactic acid, polyglycolic acid, 
and lactide glycolide copolymer (88). Yeo et al. examined the formation of bone/cementum, 
PDL, and the level of junctional epithelium between the chitosan and Biomesh groups (88). 
Their findings showed that significantly more bone and cementum were formed in the 
chitosan group than the Biomesh group (88). Additionally, a dense arrangement of osteoblast 
and cementoblast were seen on the newly formed bone by the chitosan membrane (88). 
Regarding PDL formation, Yeo et al. reported that PDL was in a more regular and dense 
arrangement in the chitosan membrane than in the Biomesh membrane (88). Regarding the 
level of junctional epithelium, Yeo et al. observed no significant difference between the 
chitosan membrane and Biomesh membrane, possibly because of loss of tight adaptation of 
the membranes in the early postsurgical period (88).  
 
       Park et al. compared the chitosan membrane and buffer membrane by immersing a 
collagen sponge into a buffer solution (89). Park et al. noticed less junctional epithelium 
migration (0.26 to 0.59 mm) in the chitosan group than the collagen group (89).  
In the same study, histological sections were prepared after eight weeks that confirmed Yeo 
et al.’s previous findings (88, 89). Histological sections showed insertion of the PDL fibers in 
new bone and new cementum, which were lined with osteoblasts and cementoblasts, 
respectively (89). These findings clearly suggest the role of the chitosan membrane in 
regenerative applications and support its superior performance compared to collagen and 
Biomesh membranes. 
 
      One strategy to treat periodontal diseases and bone defects is to utilize bioactive 
molecules such as fibroblast growth factors, recombinant human platelet-derived growth 
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factors, and platelet-rich plasma. A common drawback of this strategy is that the 
concentration of bioactive molecules decreases over time. In a study by Akman et al., 
chitosan scaffold was combined with fibroblast growth factor (90). Chitosan provided a 
controlled release of fibroblast growth factor, which makes the bioactive molecule readily 
available for periodontal ligament cells over time (90). Another study by Ji et al. revealed that 
chitosan hydrogel can work as a barrier to exclude epithelial tissues and induce PDLs to form 
new attachments (91). Well-arranged and sturdy Sharpey’s fibers were inserted into the 
alveolar and new cementum as well as into all periodontal tissues, including the capillary 
(91). 
 
1.5 Chitosan in Endodontics 
       One of the most common reasons for failures in root canal treatment is the reentry of 
microorganisms into the root canal system either because of coronal leakage due to defective 
restorations or through accessory canals distributed throughout the root canal surface. In 
addition, the root canal system is known to be complex (92, 93), which creates a challenge 
for clinicians to completely debride and disinfect root canal systems. Some bacteria has the 
ability to survive deep within dentinal tubules and accessory canals, where bacteria cannot be 
reached by mechanical and chemical preparations (94–96). This issue can lead to reinfection 
and treatment failure. 
 
       On the other hand, root canal sealers, which are considered a primary component of root 
canal filling materials, possess several drawbacks that can potentially affect the success of the 
endodontic treatment. One of these flaws is that most sealers lose their antibacterial effects 
within a short period of time (97). Moreover, some sealers do not have adequate sealing and 
flow to reach the deepest portions of dentinal tubules where bacteria can endure and cause 
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failures (98). As such, researchers have conducted several experiments to improve the 
antibacterial effect of sealers and to enhance sealers’ physical properties for better treatment 
outcomes. Utilization of nanoparticles to boost sealers’ properties appear to be advantageous 
and have gained more attention recently. Chitosan nanoparticles has been explored in 
endodontics at the laboratory level because of the promising features that chitosan has. 
Generally, the implementation of chitosan nanoparticles in endodontics has two main 
objectives: antibacterial activity and the delivery of bioactive molecules to improve stem cell 
differentiation. 
 
1.5.1 Antibacterial effects of chitosan nanoparticles on E. faecalis 
       The first breakthrough of chitosan nanoparticles in endodontics was made in 2008 by 
Kishen, who claimed that chitosan nanoparticles demonstrate significant antibacterial ability 
against enterococcus faecalis bacteria; this bacteria that is known to be broadly involved with 
secondary endodontic infections (98). This antibacterial ability can be attributed to the 
polycationic nature of chitosan nanoparticles, which allows them to interact with negatively 
charged components in the bacterial cell walls, thus deteriorating the membrane, permitting 
the leakage of essential cellular contents, and leading to the cell’s death (98).  
 
       The antibacterial activity of chitosan nanoparticles is influenced by several factors: the 
state of the bacteria, duration of exposure, and the concentration of nanoparticles in the 
solution. Shrestha et al. discovered that chitosan nanoparticles more effectively reduced 
colony-forming units (CFUs) of enterococcus faecalis in a planktonic state than on the 
biofilm structure (99). Chitosan nanoparticles yielded a complete reduction in planktonic 
bacteria within only 8–12 h, while the nanoparticles required 72 h to complete a maximum 
reduction in the biofilm structure at a concentration of 20 mg/mL (99). The concentration of 
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chitosan nanoparticles plays a crucial role in its antibacterial effects. The higher the 
concentration is, the greater the effects on bacterial cells (99).  
 
      Remarkably, the architecture of the biofilm is affected by chitosan nanoparticle treatment 
(99). Screening under a confocal microscope indicated that biofilms treated with chitosan 
nanoparticles appeared to aggregate in clusters of dead cells, with few viable cells in the 
deepest layer (99). Moreover, biofilm thickness significantly decreased from 30 m down to 
9 m after 24 h of contact with the chitosan nanoparticles (99). 
 
1.5.2 Chitosan nanoparticles with ZOE sealer 
        When incorporated into the composition of certain root canal sealers, chitosan 
nanoparticles have continued to express similar antibacterial properties (98). The 
incorporation of chitosan nanoparticles into the composition of zinc oxide eugenol (ZOE) 
sealer yields a noteworthy reduction in bacterial adherence at the dentin-sealer interface area 
compared to the effects of the original form of ZOE sealers (98, 100).  
 
      Kishen et al. conducted an experiment to assess the ability of chitosan nanoparticles to 
leach antibacterial effects from ZOE sealer (98, 101). In their experiment, a filter membrane 
was used between the sealer that contained nanoparticles and bacteria culture to mimic a 
clinical situation where bacteria can survive in the deepest part of dentinal tubules (98). 
Interestingly, chitosan nanoparticles leached out the antibacterial effect from the ZOE sealer 
and reduced bacterial cells’ viability through the filter membrane (98). In contrast, the 
original form of ZOE sealer showed no superior effect (98). Including chitosan nanoparticles 
within the composition of ZOE sealer also improved the sealers’ flow ability, which is 
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considered advantageous from a clinical perspective as this enhances the sealer’s ability to 
reach the most complex areas within the root canal system (98). 
 
       Moreover, the antibacterial effects of chitosan nanoparticles were maintained when the 
root dentin surface was treated with polyphosphorelated chitosan (100). However, chitosan’s 
antibacterial properties were moderated when root surface was treated with chitosan 
conjugated with rose bengal (a photosensitizer molecule) and followed by photodynamic 
treatment (PDT; 100). The moderating effect of rose bengal photosensitizer on the 
antimicrobial activity of chitosan may be either because the level of photodynamic radiation, 
which was supposed to induce collagen cross-linking within dentin to reduce bacterial 
adherence, was insufficient, or because anionic rose bengal might interact with cationic 
chitosan and reduce chitosan’s effects (100). In the same study, it was claimed that there was 
no significant reduction in the colonization of bacteria after one week of exposure to ZOE 
sealer containing chitosan nanoparticles compared to bacteria exposed to the original form of 
ZOE sealer (100). However, the bacteria was significantly reduced by the end of the fourth 
week in the nanoparticle-treated group, suggesting that chitosan nanoparticles maintained the 
antibacterial activity of ZOE sealer for a longer period of time (100). 
 
1.5.3 Chitosan nanoparticles with epoxy resin and MTA-based sealers 
       In addition to ZOE sealer, other types of sealers have also been tested in the presence of 
chitosan nanoparticles, including epoxy resin and MTA-based sealers (102). The 
incorporation of chitosan nanoparticles within the composition of ThermaSeal sealer 
improved antibacterial activity significantly, whereas no significant improvement was noted 
in the properties of MTApex sealer mixed with chitosan nanoparticles (102); this could be 
attributed to MTA’s ability to maintain a high pH for up to five weeks, which thus maintains 
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high antibacterial activity regardless of the presence of chitosan nanoparticles (102). 
Importantly, this high pH has was proven to increase the aggregation of nanoparticles, which 
consequently eliminates the nano-effect (103).  
 
       ThermaSeal and MTApex sealers have both shown the ability to reduce viable bacterial 
cells within one week regardless of the presence of chitosan nanoparticles, indicating the 
antibacterial potential of both sealers (102). However, after four weeks, the viable biovolume 
of bacterial cells increased significantly, suggesting that both sealers lose antibacterial 
activity over time (102). The incorporation of chitosan nanoparticles into both sealers 
resulted in a significant decrease in bacteria’s viable biovolume after four weeks, indicating 
the ability of chitosan nanoparticles to resist aging and to prolong the antimicrobial activity of 
ThermaSeal and MTApex (102). Similarly, another study showed that the persistence of the 
antibacterial activity of chitosan nanoparticles can last for up to 90 days even with the 
presence of saliva and PBS. After 90 days, the antibacterial effect was significantly reduced, 
which might be due to the interaction between ions from saliva and PBS with the positively 
charged chitosan nanoparticles, which consequently reduces chitosan’s antimicrobial effect 
(99). 
 
1.5.4 Chitosan nanoparticles with irrigation solutions 
       In addition to chitosan’s ability to improve the antimicrobial properties of different root 
canal sealers, its antibacterial capability was also assessed in combination with irrigation 
solutions to achieve optimum disinfection of the root canal system. The treatment of root 
dentin with chitosan nanoparticles after using any irrigation material provided a significant 
reduction in bacterial adherence (98). Optimum reduction (approximately 97%) can be 
achieved by irrigating root dentin surface with chlorohexidine followed by a chitosan 
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nanoparticle treatment (98). Another study found that the combination of chlorohexidine with 
chitosan nanoparticles showed significant antibacterial activity against enterococcus faecalis 
bacteria even at a low concentration (0.01%; 104). However, when a chitosan nanoparticle 
solution was used separately at a concentration of 0.012%–0.0015%, less efficacy against 
bacteria was shown compared to other types of chlorohexidine (104). Chitosan nanoparticles’ 
ability to reduce bacterial adherence to root dentin requires further investigation to confirm 
whether this effect occurs by killing bacteria immediately or by forming a bond between 
cationic nanoparticles and negative ions within root dentin, which prevents bacterial 
adherence.  
 
 On the other hand, a combination of chitosan with other molecules could serve as a 
reasonable irrigation material to further reduce bacterial adherence. For instance, 
carboxymethyl chitosan nanoparticle (CMCS) treatment demonstrated a significant reduction 
in bacteria colonization (102). Using chitosan nanoparticle solutions for final irrigation after 
either sodium hypochlorite (NaOCL) or a combination of NaOCL and EDTA significantly 
reduced total and viable bacterial biovolume, indicating chitosan’s ability to reduce the 
effects of bacterial re-entry into the root canal system after obturation, which happens usually 
as a result of filling or crown fractures (102). Chitosan nanoparticles conditioning of 
NaOCL/EDTA-treated dentin significantly enhances adherence of stem cells of the apical 
papilla (SCAPs) and results in uniform distribution of cells with well-developed lamellipodia 
and fillodopia (105). Furthermore, chitosan nanoparticles can also be utilized as a chelating 
agent to remove the smear layer that is usually formed on the dentin surface of the root canal. 
One study stated that at a volume of 3 mL and a concentration of 1.29 mg/mL, a chitosan 
nanoparticle solution can serve as a significant chelating agent after irrigation with either 
NaOCL alone or NaOCL and EDTA (106). Chitosan nanoparticles reduced the smear layer 
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significantly and uncovered dentinal tubules more clearly compared to other groups (106). 
The interpretation of chitosan’s ability as a chelating agent is that the positive amino groups 
within these molecules are bound to the calcium ions within dentin that deplete inorganic 
matter from the smear layer (106). 
 
1.5.5 Chitosan nanoparticles in regenerative endodontics 
       It has also been shown that chitosan nanoparticles can be manipulated into scaffolds to 
improve the differentiation process of SCAPs. Fabricating scaffolds by cross-linking gelatin 
with chitosan derivatives can produce scaffolds with improved mechanical properties and 
swelling ability. Gelatin/CMCS scaffolds showed reasonable porosity (74%), high swelling 
capacity (763%, which enhances scaffolds’ adaptation to the root canal walls after 
implantation), no harmful effects on SCAPs (viability rate on scaffolds was approximately 
84%), and reasonable biodegradation (approximately 40%) of the scaffold within three weeks 
(105).  
 
        In addition to scaffolds, chitosan nanoparticles were utilized as vehicles to deliver 
bioactive molecules to stem cells to improve the differentiation process in lab studies. 
Examples of various kinds of bioactive molecules that were conjugated with chitosan 
nanoparticles include dexamethasone, transforming growth factor TGF-, and bovine serum 
albumin (105, 107, 108). There are two suggested methods for loading bioactive molecules 
into chitosan nanoparticles: encapsulation and adsorption. Several studies have assessed the 
ability of a combination of chitosan nanoparticles with loaded bioactive molecules to enhance 
differentiation of SCAPs in vitro. The parameters that these studies relied on to assess SCAP 
differentiation included level of synthesis of certain proteins (such as DPSS, DMP-1 and 
ALP), biomineralization induced within SCAPs, and SCAP viability and migration. 
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 When dexamethasone was loaded into chitosan nanoparticles, the kinetic release of 
dexamethasone was initially rapid and then became a sustained release for up to four weeks 
(108). The release of dexamethasone from chitosan particles depends on loading method. It 
was shown that adsorption resulted in a higher release of dexamethasone than encapsulation 
(108); this may be because dexamethasone was entrapped within particles of chitosan in the 
encapsulation method, whereas in the adsorption method dexamethasone tends to be merely 
on the surface (108). The effect of conjugated dexamethasone with chitosan nanoparticles on 
the viability of SCAPs was assessed. Studies have found that when SCAPs were cultured 
with chitosan nanoparticles loaded by dexamethasone, no cytotoxic effect against SCAPs was 
noted (108). This finding corresponds with the results of other studies that showed no 
cytotoxicity on SCAPs when bovine serum was loaded into chitosan nanoparticles (102, 
104); this occurred because when dexamethasone was loaded into chitosan, the size of the 
particles was increased to over 100 nm, which reduced the zeta potential below the charge 
that a pure chitosan nanoparticle possesses (108).  
 
        Down-regulation of ALP and upregulation of biomineralization proteins was observed 
when SCAPs were exposed to dexamethasone conjugated into chitosan particles (105), 
indicating that SCAPs have undergone an odontoblastic pathway of differentiation. In 
addition to ALP and biomineralization, DSPP and DMP-1 proteins were significantly 
expressed by SCAPs cultured with chitosan particles containing dexamethasone (105). 
Shrestha et al. evaluated the influence of conjugated dexamethasone in chitosan particles on 
SCAPs’ adherence to dentin specimen slabs after normal disinfection protocols (109). In their 
study, the disinfection protocol was as follows: disinfection of dentin surface with 5.25% 
sodium-hypochlorite, followed by 17% EDTA; the dentin surface was then conditioned with 
chitosan nanoparticles containing dexamethasone (109). After disinfection was completed, 
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SCAPs were cultured on dentin specimens to assess the effect of the dexamethasone 
treatment on SCAP attachment (109). It was found that when dentin surfaces were treated 
with chitosan nanoparticles containing dexamethasone, SCAPs adhered to dentin walls more 
significantly than in the control group (109). This finding was explained by the fact that 
attachment proteins like fibronectins adhere to the hydrophilic surface of chitosan 
nanoparticles (109). This binding between chitosan and fibronectin provides sustained release 
of dexamethasone over time, which is critical in SCAPs’ attachment to dentin (109).  
 
        Similarly, transforming growth factor 1 is one of the bioactive molecules incorporated 
within chitosan nanoparticles and applied in regenerative endodontics. In one study, a 
comparison was made between the effect of chitosan nanoparticles loaded with TGF- and 
pure TGF- on the survival rate of SCAPs (105). The conjugation of TGF- with chitosan 
nanoparticles showed a higher rate of SCAP viability compared to the other group (105). 
Moreover, expression of DMP-1 and DSPP from SCAPs was noted at higher levels on 
scaffolds containing TGF-beta/chitosan than on those with pure TGF-beta (105); this is due 
to the sustained release of TGF- from chitosan nanoparticles, which is degradable over 
time (105). This sustained release makes TGF-beta readily available at optimum 
concentrations during certain periods of time during the differentiation process (105). 
 Additionally, a fluorescence microscopy assessment showed that the distribution of cells in 
the TGF-beta/chitosan scaffold was uniform, indicating homogenous release of the growth 
factor from chitosan nanoparticles (100). 
 
       Utilizing chitosan/TGF-beta to promote SCAP migration is another implementation of 
chitosan nanoparticles in regenerative endodontics. When TGF- was made as a scaffold 
without chitosan nanoparticles, there was a high rate of SCAP migration to the scaffold only 
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within the first 24 h, after which the rate dramatically reduced by more than 80% by the end 
of the first week (105). This was explained by the fact that the growth factor was readily 
available to SCAPs at a high concertation on the first day of cell culture, but due to a lack of 
control over the TGF-beta release, TGF- lost bioactivity over time (105). In contrast, 
incorporating chitosan nanoparticles loaded with TGF- growth factor into the scaffold 
showed a sustained rate of SCAP migration over a long period of time (105). This finding 
underscores the crucial role that chitosan nanoparticles play in controlling the release of 
TGF- to provide SCAPs with an optimum concentration of the growth factor for the 
differentiation process (105). 
 
       Equally, scaffolds containing bovine serum albumin conjugated with chitosan 
nanoparticles appeared to enhance the differentiation process of SCAPs. Shrestha et al. 
(2014) showed that the method of loading BSA into chitosan influenced SCAP migration to 
the scaffold (107). The highest rate of SCAP viability was noted when cells were exposed to 
chitosan nanoparticles loaded with BSA via adsorption (107). The rate of SCAP migration 
was dramatically decreased and eventually displayed no significant difference with cells 
exposed to BSA loaded into chitosan nanoparticles by encapsulation (107). This observation 
can be attributed to the rapid release of BSA through adsorption that rendered the 
environment favorable for SCAPs to migrate (107). Surprisingly, non-loaded chitosan 
nanoparticles, which were used as a control group, showed the lowest cell viability among 
tested groups (107); this implies a cytotoxic effect of chitosan nanoparticles on SCAPs, but it 
was not investigated further by the authors of the study (107). The difference in SCAP 
viability when exposed to BSA-loaded chitosan nanoparticles and non-loaded chitosan 
nanoparticles can be attributed to particle size (107). Loading chitosan nanoparticles with 
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BSA resulted in an increase in total particle size and consequently could have reduced the 
nanoparticles’ penetration of cell membranes, thereby enhancing cells’ viability (107).  
 
       In addition to the antimicrobial effects of chitosan and its role in enhancing 
differentiation in SCAPs, there are other applications in which chitosan nanoparticles are in 
close contact with pulp tissue. In a study by Shrestha in 2012, it was found that when 
chitosan nanoparticles were cultured with bacterial cells in the presence of pieces of pulp 
tissue, the antibacterial effect of the chitosan nanoparticles was dramatically reduced (110). 
One explanation for this is a possible interaction between chitosan nanoparticles and pulp 
tissues that reduced the antibacterial power of chitosan. Such findings highlight the necessity 
to investigate the biocompatibility of chitosan nanoparticles on human dental pulp cells to 
avoid any harmful effects on dental pulp in clinical applications. 
 
1.6 Rationale and Clinical Significance of This Study 
 
       In many in vitro studies, chitosan nanoparticles were employed either as antibacterial 
agents or as vehicles to deliver bioactive molecules. In some of the proposed applications, 
there is the possibility of direct interaction between chitosan nanoparticles and dental pulp. 
Given the nanotoxicity of metallic and inorganic nanoparticles, such as silver and silica 
nanoparticles, on different cell cultures, it is essential to evaluate the biocompatibility of 
chitosan nanoparticles on normal human dental pulp cells. It is critical to determine the most 
appropriate concentrations and particle sizes of chitosan nanoparticles for safe usage to 





























Chapter 2: HYPOTHESIS  
 
It was hypothesized that chitosan particles at certain nano-levels could cause 
dose-and size-dependent cytotoxic or genotoxic effects on normal human 
dental pulp cell cultures.  
The null hypothesis (H0) is that there is no difference in cytotoxicity and 
genotoxicity between the experimental sample groups containing chitosan 
particles in different sizes and doses. 































Chapter 3: OBJECTIVES OF THE STUDY  
Objective 1  
To measure the cellular attachment efficiency of normal human dental 
pulp cells cultured on plastic tissue culture plates containing culture media 
with various sizes and doses of chitosan nanoparticles (0.5 mg/mL, 1 mg/mL, 
2 mg/mL, and 4 mg/mL) at 16 h and to compare this to attachment efficiency 
of cells grown in media without particles (control).  
 
Objective 2  
  To quantify cellular proliferation rates of normal human dental pulp 
cells grown in culture media that contain the same various sizes and doses of 
chitosan nanoparticles (0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL) at 3, 
7, and 14 days and to compare this to the proliferation rates of normal human 
dental pulp cells grown in media without particles (control) at the same time 
points.  
 
Objective 3  
To evaluate the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells grown in culture media that contain the same 
various sizes and doses of chitosan nanoparticles (0.5 mg/mL, 1 mg/mL, 2 
mg/mL, and 4 mg/mL) at 3, 7, and 14 days and to compare this to the 
cytotoxicity of normal human dental pulp cells grown in media without 






Objective 4  
To evaluate the expression of phosphorylated H2AX histones in 
normal human dental pulp cells grown in culture media that contain the same 
various sizes and concentrations of chitosan nanoparticles (0.5 mg/mL, 1 
mg/mL, 2 mg/mL, and 4 mg/mL) after 24 h and to compare this to the 
pH2AX expression in normal human dental pulp cells grown in media 
without particles (control) at the same time point. 
 
Objective 5  
To evaluate the expression of micronuclei and nuclear buds in normal 
human dental pulp cells grown in culture media that contain the same various 
sizes and concentrations of chitosan nanoparticles (0.5 mg/mL, 1 mg/mL, 2 
mg/mL, and 4 mg/mL) at 24 h and to compare this to the expression of 
micronuclei and nuclear buds of normal human dental pulp cells grown in 
media without particles (control) at the same time point. 
 
Objective 6  
To evaluate uptake of the same various sizes and concentrations of 
chitosan nanoparticles (0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL) by 















































1.8 Approvals and Training 
       This study was approved by the Institutional Biosafety Committee at Boston University 
(IBC #16-661). All necessary human subject training was completed through the 
Collaborative Institutional Training Initiative (CITI). Online lab training was provided 
through the Office of Research at Boston University. Exempt review (IRB# H-33173) from 
the human subjects was granted from the Institutional Review Board to use biological waste 


























1.9.1 Culture medium preparation 
 
       Bottles of 500 mL Basal Medium Eagle (BME) culture media purchased from Fisher 
Scientific were used to culture cells for all experiments. Under sterile conditions, 50 mL of 
BME was discarded to allow enough room for other contents. Using a micropipette, 50 mL of 
10% fetal bovine serum (FBS, Atlanta Biologicals), 1x penicillin antibiotic (100 U/mL), 1x 
streptomycin (100 µg /mL), and amphotericin B antifungal (0.25 µg/ml) were added. Bottles 
of culture media were gently mixed and then stored at 4 °C for later use. 
 
1.9.2 Cell culture 
1.9.2.1 Isolation of dental pulp explants 
      Isolation of dental explants was done following the same protocol published by 
Stanislawski et al. with a few modifications (111). Freshly extracted third molars from 
patients aged between 18 to 25 years old were obtained from an oral surgery clinic at Boston 
University and utilized to isolate dental pulp cells. All obtained teeth were pristine, with no 
restoration or caries, and the process of dental pulp tissue isolation was carried out within 2 h 
of the extraction time. Using a carbide surgical round bur (size #8, US Dental Depot, FL, 
USA), a groove was made on the crown extending from the mesial to the distal marginal 
ridges of the tooth without exposing the pulp. Then, a Chandler bi-bevel bone chisel (Hu-
Friedy) was placed into that groove and was hit by a hammer to split the tooth open into two 
halves. With a sterile explorer and scissor, only the coronal pulp was dissected and cut into 
small pieces. The small pieces of pulp tissue were placed in a petri dish that contained sterile 
PBS. All petri dishes were then transferred to a class II bio-safety cabinet, and pulp tissues 
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were moved to a 25-cm culture flask containing BME culture media, fetal bovine serum, 
antibiotics such as penicillin and streptomycin, and antifungal agents such as amphotericin B.  
 All culture flasks were then kept in an incubator at 37 °C with 5% CO2 (Water-
Jacketed CO2 incubator, Thermo Fisher Scientific, USA), and the culture media were 
replaced by a fresh one every 3 days until the cells reached 80% confluence. 
 
1.9.2.2 Primary cell culture 
        The process of primary cell culture in the 25- cm2 culture flasks took up to six weeks 
before an appropriate confluence was achieved (i.e., nearly 80% of cell confluence). During 
the first week, culture media were exchanged with fresh ones every day. After the first week, 
replacement of the culture media was done every 3 days. The culture media exchange process 
started with aspirating old media in a sterile environment inside the biosafety cabinet. 
Aspiration of culture media was done carefully, without touching either pulp tissues or the 
bottom surface of the flasks where cells are expected to attach. Then, 3 mL of warm sterile 1x 
PBS was gently added to cover and wash the bottom surface of the flask. After this, PBS was 
aspirated, and 8 mL of a fresh culture medium was added to each flask. Tissue culture flasks 
were then returned to the incubator until the next round of media exchange.  
       Pulp tissue pieces were preserved during the culture media exchange process, especially 
in the first 7 days. However, these tissues were eventually removed from the flasks to allow 
more room for cells to grow and to prevent any potential microbial infections. Primary 
culture continued until cells reached 80% confluence in the 25-cm2 flasks, which was 




1.9.2.3 Secondary culture 
       When cells covered almost 80% of the 25-cm2 culture flask’s surface area, it was time to 
expand the culture to a second passage. Culture media were aspirated, and a warm 1x PBS 
was used to wash the cells. Then, 1 mL of EDTA-trypsin was added to dissociate cells from 
the flasks. After the addition of EDTA-trypsin, all flasks were kept inside the incubator for 3 
min. Under a light microscope, floating cells were observed. The action of EDTA-trypsin was 
stopped by adding 10 mL of BME. Culture media that contained cells were later collected in 
a centrifuge tube for the centrifugation process. Cells were centrifuged for 5 min at a speed of 
1,000 rpm. After centrifugation, cells were collected at the pellet of the tube. Culture media 
were aspirated carefully so as not to touch the cells in the pellet. Then, cells were 
resuspended in 10 mL of fresh BME. After this, cells were transferred to 225-cm2 culture 
flasks, and another 25 mL of BME was added. At 16 h, cell attachment to the flasks’ bottom 
surface was assessed using the light microscope. Flasks were kept inside the incubator until 
needed.  
       The maintenance of the cell cultures was carried out in the same way as described above, 
but 10 mL of 1x PBS was used for washing and 30 mL of fresh BME were added every 3 
days. When cells reached 80% confluence in the 225-cm2 culture flasks (as evaluated 
microscopically), the cells were detached from the flasks to be utilized in the experiments. 
Cell detachment was accomplished first by aspirating culture media, washing with warm 1x 
PBS, and then adding 3 mL EDTA-trypsin while gently shaking the flasks for 3 minutes. The 






1.9.2.4 Cell counting 
       The cells were subsequently counted using a hemacytometer (Reichert-Jung) under a 
microscope, as described by Freshney (112). Cells were counted by adding 40 μL of the 
suspended cells to the edge of the hemacytometer chamber to allow the suspended cells to 
run out of pipette and be drawn under the cover slip via capillary action. A light microscope 
with 20x magnification was used to focus on the grid lines in the chamber. Cells were 
counted in the largest area bounded by three parallel lines, which is one square millimeter. 

















1.9.3 Chitosan solution preparation 
       In the present study, 0.1% acetic acid was used to dissolve the chitosan molecules 
because chitosan can only be dissolved in acidic media. The 1% acetic acid was diluted to 
0.1% by adding 10 mL of acetic acid into 90 mL of distilled water. The reason for using 0.1% 
acetic acid was to produce chitosan solutions with a neutral pH to avoid any confounding 
effects from acidity on the viability of cells.  
       According to Gan et al., there are several factors that might affect the size of the 
produced nanoparticles (113). These factors include chitosan solution concentration, ratio 
between chitosan solution and sodium-triphosphate solution (cross-linker), and chitosan 
molecular weight. The findings of Gan et al.’s study indicated that as the concentration of the 
chitosan solution increases, the size of the nanoparticles produced will increase as well. In 
addition, the ratio between chitosan and sodium-TPP and chitosan molecular weight showed 
an analogous effect with particle size. As the factors listed above increase, the size of the 
generated nanoparticles increases accordingly. In Gan et al.’s work, two concentrations of 
chitosan solutions were used, 1 mg/mL and 3 mg/mL, to produce 50 nm and 350 nm chitosan 
nanoparticles, respectively. The ratio and molecular weight were kept consistent during the 
nanoparticles’ production. The ratio between chitosan and sodium-TPP solutions was kept at 








       For the 1 mg/mL chitosan solution, 100 mg of chitosan powder was first weighted on a 
scale. Then, chitosan powder was incrementally added into 100 mL of 0.1% acetic acid while 
the acid was stirring. The chitosan solution was then left to stir for 3 h at room temperature to 
ensure complete dissolution of the chitosan. After that, the clarity of the chitosan solution was 
evaluated for any powdery residue.  
       The chitosan solution at a concentration of 3 mg/mL was prepared using the same 
method except that 300 mg of chitosan powder was weighed on the scale instead of 100 mg.  
The ratio between the chitosan solution and the sodium-TPP solution was planned to be 3:1. 
For this reason, the sodium-TPP solution at a concentration of 0.25 mg/mL was made to 
interact with the 1 mg/mL chitosan solution to generate smaller nanoparticles. At the same 
time, 1 mg/mL of TPP solution was prepared to interact with 3 mg/mL of chitosan solution to 
produce the bigger sizes.  
       Regarding molecular weight, medium molecular weight, 310 kDa, was used. This 
molecular weight was chosen based on previous antibacterial studies supporting that 
molecular weight is directly proportional with chitosan’s antibacterial activity. However, it 
would have been challenging to utilize chitosan at a high molecular weight in this project due 









1.9.4 Chitosan nanoparticle preparation  
        Chitosan nanoparticles were prepared with the ionic gelation method as described by 
Calvo but with certain modifications (114). According to the FDA and the European 
Commission, nanoparticles can be defined as materials that contain 50% or more particles 
below the size of 100 nm. Therefore, in the present study, nanoparticles smaller and larger 
than 100 nm were produced to investigate the nano-effect. Chitosan powder (Medium 
Molecular Weight, 190,000–310,000 Da, 85% degree of deacetylation, Sigma-Aldrich, USA) 
at masses of 50 mg and 300 mg was dissolved in 0.1% (v/v) acetic acid to create chitosan 
solutions at concentrations of 0.5 mg/mL and 3 mg/mL. The pH of chitosan solutions was 
raised to 7 using 1 mol/L sodium hydroxide (NaOH). Both chitosan solutions were then 
filtered and stirred with 0.25 mg/mL and 1 mg/mL sodium-triphosphate solutions (Sodium-
TPP; Fisher Scientific, USA) for one hour to produce 50 nm and 350 nm nanoparticles, 
respectively (113). After stirring, 2 mL of the chitosan-sodium-TPP solution, which 
contained 2 mg of nanoparticles, were added to the centrifugation tube. The 2 mg 
nanoparticles were then collected by centrifuging the chitosan-TPP solutions at 13,000 rpm 
for 4 minutes. The supernatant was discarded and the pellet, which contained 2 mg of 
nanoparticles, was suspended in various volumes of BME to create concentrations of 0.1 
mg/mL, 0.5 mg/mL, 1 mg/mL , 2 mg/mL, and 4 mg/mL. These concentrations were chosen 








1.9.5 Dynamic light scattering for chitosan nanoparticles characterization 
       All nanoparticles were sonicated at 60% amplitude for 5 minutes for better dispersion. 
Particle size distribution, mean particle sizes, and zeta potential were assessed twice by 
dynamic light scattering (90 Plus Particle Size Analyzer, NY, USA) to assess particles 
agglomerations, first immediately after nanoparticle suspension and again after 3 days.  
 
1.9.6 Transmission electron microscope for chitosan nanoparticle characterization 
      Morphological assessment of nanoparticles was performed using a transmission electron 
microscope (Tecani Osiris). Nanoparticles were suspended in distilled water and diluted to a 
concertation of 0.001 mg/mL to allow better visualization. A syringe with 30-gauge needles 
was used to aspirate the nanoparticles from the tube. One drop was put on a copper grid to be 
utilized for evaluation. The excess solution was removed by using a filter paper around the 
periphery of the grid. Then, the grid was put on a hot plate to evaporate the rest of the 











1.9.7 Cell attachment efficiency experiment 
       The attachment efficiency of the human dental pulp cells was evaluated with and without 
the presence of different concentrations and sizes of chitosan nanoparticles via crystal violet 
assay. The evaluation was done at 16 hours based on previous pilot studies conducted in the 
lab that indicated that human dental pulp cells showed optimal attachment at 16 hours from 
seeding time. In addition, 16 hours precedes the first proliferation cycle, which usually occurs 
at 24 hours.  
After the cell counting was completed as previously mentioned, cells were seeded in 
96-well plates (Fisher Scientific) at a density of 1.5×104 cells per well. For the control group, 
cells were seeded only with BME culture media that did not contain any nanoparticles. For 
the smaller nanoparticles group, cells were seeded with BME culture media containing 50 to 
67 nm chitosan nanoparticles at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 
mg/mL. For the larger nanoparticles group, cells were seeded with culture media containing 
318 to 350 nm at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL. All plates 
were then kept in an incubator at 37 °C for 16 hours, after which the culture media were 
discarded, and all wells were washed thoroughly with warm phosphate-buffered saline (PBS) 
to eliminate the remnants of nanoparticles. Thereafter, cells were fixed by adding 50 µL of 
10% neutral buffered formalin (Sigma) for 1 h at room temperature. The formalin was then 
discarded, and the cells were washed with PBS to remove any remnants from the fixer 
solution. Then, the fixed cells were stained by adding 50 µL of 0.2% crystal violet stain 
(Sigma-Aldrich) for another hour. After an hour, all wells were washed again with PBS to 
remove any unbound stains. All plates were then transferred to the spectrophotometer to 
measure the density of the stained cells at a wavelength of 590 nm. The data obtained from 
the spectrophotometer was compared to that from the standard curve to calculate the cell 
number in each well, and these were presented as percentages. 
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1.9.8 Cell proliferation assay via crystal violet staining 
       The proliferation rate of the human dental pulp cells cultured with or without different 
concentrations and sizes of chitosan nanoparticles was assessed using crystal violet stain 
assay. The proliferation rate was assessed at three time points: 3 days, 7 days, and 14 days. 
The second passage of the cell culture was utilized in this experiment. Cell counting was 
done prior to cell seeding in the same way described above. After that, 800 cells per well 
were seeded in 96-well plates (Falcon® 96-Well Clear Flat Bottom, TC-Treated Culture 
Microplate, with Lid, Corning, USA) contained in 100 microliters of BME culture media and 
incubated at 37 °C with 5% CO2 for 16 hours to allow a sufficient attachment. After 16 hours, 
the cell attachment to the wells’ surfaces was confirmed by a light microscope in all wells. 
Following that, the culture media were removed from all wells, and fresh culture media that 
did not contain any nanoparticles were added for the control group. For the smaller 
nanoparticles group, culture media containing 50 to 67 nm chitosan nanoparticles at 
concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL were added. For the larger 
nanoparticles group, culture media containing 318 to 350 nm chitosan nanoparticles at 
concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL were added.  
For the three-day experiment, by the end of the third day, the culture media were 
aspirated from all wells, followed by washing each well with 100 microliters of warm PBS. 
After that, the fixation process was accomplished by adding 50 microliters of 10% formalin 
in each well, and the culture plates were kept at -4 °C refrigerator for 24 hours. After that 
period, the formalin was aspirated from all wells, followed by washing each well with warm 
PBS. After drying all wells, 50 microliters of 0.2% crystal violet were added in each well for 
one hour. Then the crystal violet was aspirated, and each well was washed thoroughly with 
PBS until a clear PBS solution was observed. The culture plates were then transferred to the 
spectrophotometer to measure the intensity of the crystal violet stain for each group at a 
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wavelength of 590 nm. The readings recorded from the spectrophotometer were converted 
into folds for data expression. The folds were calculated as follows: dividing the cell number 
on the day of the experiment by the number of seeded cells. 
For the other predetermined timepoints (day 7 and day 14), the culture media were 
replaced periodically every three days under aseptic conditions to avoid microbial 
contamination. At the day of the experiment, either day 7 or day 14, culture media aspiration, 
cell washing with PBS, fixation with formalin, staining with crystal violet, measuring the 
stain intensity for all groups, and then converting the data into folds were all completed 
following the same protocol as above.  
 
1.9.9 Mitochondrial dehydrogenase enzyme activity 
 The viability of human dental pulp cells in the presence of different concentrations and sizes 
of chitosan nanoparticles was evaluated by assessing the activity of mitochondrial 
dehydrogenase enzyme, which, in viable cells, has the ability to convert tetrazolium salt into 
non-soluble formazan purple compound (115). The ab112118 Cell Cytotoxicity Assay Kit 
purchased from the Abcam USA company was used to assess the activity of the 
dehydrogenase enzyme. 
 Cell counting was done prior to the experiment in the same way described above. Cells at 
a density of 800 cells per well were seeded in a 96-well black plate with a clear bottom 
(Corning Incorporated, USA), and the culture plates were stored under the same conditions as 
in the previous experiment. After 16 hours from seeding, the cell attachment in each well was 
ensured using a light microscope. After confirming cell attachment, the culture media was 
replaced with a fresh plane culture media for the control group. For the smaller nanoparticles 
group, the culture media were replaced with new ones  containing 50 to 67 nm chitosan at 
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concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL. For the larger nanoparticles 
group, the culture media were replaced by new media containing 318 to 350 nm at 
concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL. Cell viability was tested at 
three predetermined points of time: 3 days, 7 days, and 14 days. 
On the day of the experiment (i.e., day 3, 7, or 14), the culture media in all wells were 
aspirated. Then warm PBS was added to wash the cells thoroughly. After that, diluted culture 
media with PBS were added in each well. The reason for diluting the culture media at this 
step was to avoid a false positive reading from the background. Following that, 20 microliters 
of tetrazolium salt were added in each well in a dark room. All culture plates were covered by 
aluminum foil and kept in an incubator at 37 °C for four hours. Then the culture plates were 
transferred to the spectrophotometer to measure the absorbance of formazan compound 
formed in each well. Measurements were made at two different wavelengths: 570 and 605 
nm. Data was then plugged into the following equation to calculate the percentage of the 
viability for each group: 
% Cell viability = 100 × (Rsample-R0)/(Rcontrol-R0) 
Rsample is the ratio of the 570 nm reading over the 605 nm reading for the tested groups.  
R0 is the ratio of the 570 nm reading over the 605 nm reading for the background.  








1.9.10  Phosphorylation of H2AX histones genotoxicity experiment 
       DNA double strand breaks were assessed by evaluating the level of phosphorylated 
H2AX histones as described before but with modifications (116). Phosphorylation of H2AX 
histones in human dental pulp cells was assessed at 24 hours after exposure to various 
concentrations and sizes of chitosan nanoparticles.  
Prior to the experiment, all agents were prepared in a sterile environment under a class II 
biosafety cabinet according to manufacturer’s instructions. Briefly, stock solutions were 
freshly prepared on the day of the assay. Component A was prepared by adding 1.8 µL of 
Image-iT® Dead Green viability stain to 6 mL of the culture medium. A fixative solution was 
prepared by adding 1.5 mL 16% aqueous paraformaldehyde solution to 4.5 mL PBS. The 
permeabilization solution was prepared by adding 15 µL of Triton® X-100 to 6 mL PBS. A 
blocking buffer was prepared by dissolving 0.25 g bovine serum albumin (BSA) in 25 mL 
PBS. The primary antibody solution was prepared by adding 6 µL pH2AX antibody to 6 mL 
of the blocking buffer. A secondary 55 antibody/counterstain solution was prepared by 
adding 3µL of Alexa Fluor®555 goat anti-mouse IgG and 1 µL of Hoechst 33342 to 6 mL 
blocking buffer. 
 For the experiment, human dental pulp cells were seeded in 96-well plates at a density of 
1.5×104 cells per well and were grown overnight in a humidified atmosphere at 37 °C with 
5% CO2. After 16 hours, cell attachment in all wells was ensured using a light microscope. 
The culture medium in the control group was replaced with a fresh one that did not contain 
nanoparticles. Cells in the study groups were cultured with fresh culture media containing 50 
to 67 nm and 318 to 350 nm-sized chitosan nanoparticles at concentrations of 0.1 mg/mL, 0.5 
mg/mL, and 2 mg/mL. All plates were returned to the incubator at 37 °C for 24 hours. After 
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that time period, the culture media were aspirated, and cells in all groups were washed with 
PBS to remove any remnants of nanoparticles.  
Cells were then fixed by adding 50 microliters of 10% neutral buffered formalin for one 
hour at room temperature. After that, the formalin was washed away with PBS, and cells 
were permeabilized by adding 10 microliters of Triton X-100 for 15 minutes to allow the 
passage of antibodies through the cellular membrane. Following that, unwanted areas within 
cells were blocked using the blocking buffer (0.25 g of BSA in 25 mL PBS) for 60 minutes to 
avoid any false positive results. The blocking buffer was removed, and phosphorylated 
H2AX histones in human dental pulp cells were probed by incubating the cells with mouse 
monoclonal anti-pH2AX primary antibodies for 60 minutes in the dark. Then florescence-
labeled anti-mouse secondary antibodies were added for another 60 minutes in the dark to 
facilitate the visualization of the phosphorylated H2AX nuclear foci. Cells were then washed 
four times with PBS and counterstained by DAPI stain for 10 minutes. The intensity of the 
phosphorylated H2AX histones was measured using a florescence spectrophotometer (Ex/Em 
= 555/565 nm). To calculate the percentage of pH2AX fluorescence intensity, the data from 
the spectrophotometer was then plugged into the following equation: pH2AX fluorescence 
intensity = ( fluorescence of control- fluorescence of test)/ fluorescence of control x 100.  
In addition, florescence images of human dental pulp cells were obtained at 40X 
magnification using the Nikon deconvolution wide-field epifluorescence system equipped 







1.9.11 Cytokinesis block micronucleus assay 
 
       Chromosomal damage in hDPCs exposed to various sizes and concentrations of CS-
nanoparticles was assessed using a cytokinesis-block micronucleus (CBMN) assay. After 
counting 800 cells per well, the cells were plated in 96-well plates and allowed to attach for 
16 hours. Cell attachment was confirmed after 16 hours, as mentioned in the previous 
experiments. For study groups, cells were exposed to the same sizes and doses of CS-
nanoparticles considered for the pH2AX experiment. For control group, cells were cultured 
with a culture medium that did not contain nanoparticles.  
Prior to the experiment, cytochalasin-b agent, which blocks cell division, was prepared as 
shown in photo 1. The cytochalasin-b (cyto-b) stock solution (Sigma) comes in 
concentrations of 10000 microg/mL in a volume of 200 microliters. To prepare cyto-b, 60 
microliters of the stock solution were taken, which contained 600 microg of cyto-b, and 
added into a 1 mL microtube that contained 940 microliters of the culture medium. This 
diluted the concentration of cyto-b from 10000 microgram/mL down to 600 microg/mL. 
Further dilution was caused by adding 100 microliters of the 600 microg/mL cyto-b to 900 
microliters of the culture medium, which brought the final concentration down to 60 
microg/mL (the concentration that was used for the experiment). Cytochalasin-b was then 
stored at -20˚C for further use. On the day of the experiment, 20 microliters of the prepared 
cytochalasin-b were added into each well containing 100 microliters of the culture medium, 








For the experiment, after 24 hours of exposure to nanoparticles, cell division was blocked 
by adding 10 g/mL cytochalasin-b for 18 hours. Thereafter, the cells were washed with 
PBS, fixed with 10% formalin, and stained with DAPI stain. Using the epifluorescence 
microscope at a magnification of 40X, the frequencies of micronuclei and nuclear buds were 
recorded in 1,000 binucleated cells per well, following the same protocol established by 
Fenech (117).  
 
 
Photo 2: Cytochalasin-b effect on normal human dental pulp cells  
Note: A microscopic picture shows the formation of binucleated cells, which is an indication 





The criteria for selecting binucleated cells suitable for scoring micronuclei and nuclear 
buds included the following (117): The two nuclei in a binucleated cell should have intact 
nuclear membranes and be situated within the same cytoplasmic boundary. The two nuclei in 
a binucleated cell should be approximately equal in size, staining pattern, and staining 
intensity. The two nuclei within a BN cell may be attached by a nucleoplasm bridge, which is 
no wider than 1/4th of the nuclear diameter. The two main nuclei in a BN cell may touch but 
ideally should not overlap each other. A cell with two overlapping nuclei can be scored only 
if the nuclear boundaries of each nucleus are distinguishable. The cytoplasmic boundary or 
membrane of a binucleated cell should be intact and clearly distinguishable from the 
cytoplasmic boundary of adjacent cells. The cell types that should not be scored for the 
frequency of MNi and NBuds frequency include mono- and multinucleated (with three or 
more nuclei) cells and cells that are necrotic or apoptotic. 
The criteria for scoring micronuclei MNi included the following (117): Morphologically, 
micronuclei should be identical to but smaller than the main nuclei. The diameter of MNi in 
human dental pulp cells usually varies between 1/16th and 1/3rd of the mean diameter of the 
main nuclei, which corresponds to 1/256th and 1/9th of the area of one of the main nuclei in a 
BN cell, respectively. MNi are non-refractile, and they can therefore be readily distinguished 
from artifacts such as staining particles. MNi are not linked or connected to the main nuclei. 
MNi may touch but not overlap the main nuclei, and the micronuclear boundary should be 
distinguishable from the nuclear boundary. MNi usually have the same staining intensity as 
the main nuclei, but occasionally staining may be more intense.  
The criteria for scoring nucleoplasmic bridges (NPBs) were as follow (117): An NPB is 
a continuous DNA-containing structure linking the nuclei in a binucleated cell. NPBs 
originate from dicentric chromosomes (resulting from misrepaired DNA breaks or telomere 




1.9.12 Cellular uptake of FITC-tagged chitosan nanoparticles 
 Chitosan was labeled with fluorescein isothiocyanate (FITC) stain and cultured with 
hDPCs to investigate the nanoparticles’ internalization. The concept behind labeling chitosan 
with FITC stain is based on the stable covalent interaction between amino groups of chitosan 
and the isothiocyanate root (N=C=S) of FITC (118). Chitosan solutions at concentrations of 
0.5 mg/mL and 3 mg/mL were prepared, as mentioned previously. Both chitosan solutions 
were then stirred with 10 mL of 2 mg/mL FITC solution overnight in the dark to produce 
FITC-tagged chitosan. Thereafter, FITC-tagged nanoparticles at sizes from 50 to 67 nm and 
318 to 350 nm were prepared using the same ionic gelation method previously described. 
Centrifugation was utilized at 13000 rpm for four minutes to collect 2 mg of FITC-tagged 
nanoparticles. To discard any unreacted FITC, the collected FITC-tagged nanoparticles were 
resuspended in distilled water and centrifuged several times until no florescence was 
observed in the supernatant, as measured by the spectrophotometer.  
The pellet, which contained 2 mg of chitosan-FITC nanoparticles, was then resuspended 
in various volumes of the culture media to create concentrations of 0.1 mg/mL, 0.5 mg/mL, 
and 2 mg/mL. The nanoparticles were then cultured in 96-well plates with hDPCs at a density 
of 1.5×104 cells per well for 24 hours. Thereafter, the media were discarded, and the cells 
were incubated with trypan blue for a minute to quench extracellular fluorescence to 
distinguish between the internalized nanoparticles and those that remained in the extracellular 
milieu (119). The intensity of the FITC was then measured using a fluorescence 
spectrophotometer (Ex/Em = 495/519 nm). For visualization by the epifluorescence 
microscope, the cells were fixed using 10% formalin, and the nuclei were counterstained with 
4′,6-diamidino-2-phenylindole (DAPI). The internalized nanoparticles were observed 
microscopically at 40X magnification. 
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1.10 Statistical analysis 
 
Data are presented in means and standard deviations (SDs). The means and SDs of human 
dental pulp cell attachment and proliferation at 16 hours, 3 days, 7 days, and 14 days were 
calculated. Cytotoxicity assay (viability percentage) was calculated at 3 days , 7 days, and 14 
days. Genotoxicity assay was presented by the pH2AX mean average intensity at 24 hours. 
All experiments were performed in quadruplicate (n = 4).  
Finally, the statistical analysis was performed using IBM SPSS (version 26) software in 
chi-square and one-way variance with a Tukey multiple comparison post hoc test to detect the 






















































Chapter 5: Results 
 
5.1 Chitosan nanoparticles characterization 
 
       The chitosan nanoparticles characterization, as reported from DLS, is shown in figures 1, 
2, 3, and 4. In short, the size distribution of the smaller particles group, immediately after 
ultrasonic cavitation in the culture medium, ranged from 25 nm to 116 nm with a median of 
54 nm and a mean of 50 nm. Three days after ultrasonic cavitation, the size distribution 
ranged from 26 nm up to 133 nm with a median of 60 nm and a mean of 67 nm. For the 
larger particles group, the distribution of sizes ranged from 107 nm to 685 nm with a median 
of 271 nm and a mean of 318 nm immediately after ultrasonic cavitation in the culture 
medium. Three days later, the particle size distribution had changed slightly to 125 nm up to 
740 nm with a median of 305 and a mean of 350 nm. Such findings point to the 
nanoparticles’ stability with no significant agglomeration observed within three days after 
sonication treatment. The zeta-potential was 38.2 mV and 35.6 mV for groups 50 nm and 318 
nm, respectively. TEM images further confirmed the particle size to be 50 nm for the smaller 






































































2.2 Attachment efficiency  
 
2.2.1 Attachment efficiency of normal human dental pulp cells affected by different  
doses of 50 nm chitosan at 16 hours 
 
      The attachment efficiency of normal human dental pulp cells cultured with various 
concentrations of 50 nm chitosan at 16 h is shown in figure 5. It was noted that at 16 hours, 
all concentrations of 50 nm chitosan significantly reduced the attachment efficiency of 
hDPCs (p < 0.05) as compared to the control group. The reduction in cell attachment in the 
nanoparticle-treated groups was observed to be in a dose-dependent manner as 2 mg/mL and 
4 mg/mL significantly showed lower attachment efficiency as compared to the rest of the 












2.2.2 Attachment efficiency of normal human dental pulp cells affected by different  
doses of 350 nm chitosan at 16 hours 
 
       The attachment efficiency of normal human dental pulp cells cultured with various 
concentrations of 50 nm chitosan at 16 h is shown in figure 6. All nanoparticle-treated groups 
showed comparable attachment efficiency to the control group, which suggests no significant 
























2.2.3 Attachment efficiency of normal human dental pulp cells affected by different  
sizes of chitosan nanoparticles at 16 hours 
 
The attachment efficiency of normal human dental pulp cells cultured with various sizes 
and concentrations of chitosan nanoparticles at 16 h is shown in figure 7. The findings of this 
experiment suggest that the attachment of human dental pulp cells in the nanoparticle-treated 
groups showed a significant reduction in attachment efficiency in a size-associated manner 
when compared to the control (p < 0.05). In comparison to each tested concentration, cells 
cultured with 50 nm displayed significantly lower attachment efficiency than those cultured 

























































2.3 Proliferation rate 
2.3.1 Proliferation of normal human dental pulp cells affected by different doses of  
50 nm chitosan at different time intervals 
 
The influence of various concentrations of 50 nm chitosan on the proliferation rates of 
normal human dental pulp cells after three days of exposure is illustrated in figure 8. After 
three days’ exposure, cells exposed to 50 nm chitosan at concentrations of 0.5 mg/mL, 1 
mg/mL, and 2 mg/mL expressed similar proliferation rates when compared to the control 
group. A higher concentration (4 mg/mL) significantly reduced the proliferation rate when 























The influence of various concentrations of 50 nm chitosan on the proliferation rates of 
normal human dental pulp cells after seven days of exposure is illustrated in figure 9. After 
seven days’ exposure to 50 nm chitosan, cells cultured with concentrations of 0.5 mg/mL and 
1 mg/mL showed a slower proliferation rate than the control group; however, the finding was 
not statistically significant (P > 0.05). Higher concentrations of 2 mg/mL and 4 mg/mL 
significantly reduced the proliferation rate as compared to the control and lower 
concentration groups (P < 0.05). The reduction in the proliferation rate did not show a dose-
dependent response as there was no statistical difference between the proliferation rates of 

















The influence of various concentrations of 50 nm chitosan on the proliferation rates of 
normal human dental pulp cells after 14 days’ exposure is illustrated in figure 10. After 14 
days of exposure to 50 nm, all cells in the nanoparticle-treated groups showed significantly 
slower proliferation rates when compared to the control (P < 0.05). This reduction in 
proliferation rates appeared to be in a dose-dependent manner. There was a significant 
decrease in cell proliferation as the concertation of 50 nm chitosan increased from 0.5 mg/mL 
to 4 mg/mL, where the lowest cell number was observed in the 4 mg/mL group (fewer than 


















2.3.2 Proliferation of normal human dental pulp cells affected by different doses of  
350 nm chitosan at different time intervals 
 
The influence of various concentrations of 350 nm chitosan on the proliferation rates of 
normal human dental pulp cells after three days of exposure is illustrated in figure 11. After 
three days, all cells treated with various concentrations of 350 nm chitosan displayed a 
comparable proliferation rate with the control group (P > 0.05). Chitosan at a size of 350 nm 
and concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL did not reduce the 



























Figure 11: Proliferation rate of human dental pulp cells grown for three days in culture media 
supplemented with various concentrations of 350 nm chitosan 
Note: The data are presented as the means of four experiments with error bars indicating 
standard deviations. The data are presented in folds, which were calculated by dividing the 




































Proliferation rate of hDPCs exposed to 
various concentrations of 350 nm 
chitosan nanoparticles, day 3
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The influence of various concentrations of 350 nm chitosan on the proliferation rates of 
normal human dental pulp cells after seven days’ exposure is illustrated in figure 12. After 
seven days of exposure to 350 chitosan nanoparticles, cells behaved in a similar manner as 
seen in the three-day experiment, without any significant reduction in proliferation rate. In all 

































Figure 12: Proliferation rate of human dental pulp cells grown for seven days in culture 
media supplemented with various concentrations of 350 nm chitosan  
Note: The data are presented as the means of four experiments with error bars indicating 
standard deviations. The data are presented in folds, which were calculated by dividing the 
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The influence of various concentrations of 350 nm chitosan on the proliferation rates of 
normal human dental pulp cells after seven days’ exposure is illustrated in figure 13. After 14 
days of exposure to 350 nm chitosan, a notable reduction in the proliferation rate was seen. 
All cells in nanoparticle-treated groups demonstrated a significantly slower proliferation rate 
as compared to the control group (P < 0.05). The reduction in the proliferation rate notably 
reduced as the concentration of 350 nm chitosan increased, where the lowest proliferation 



















2.3.3 Proliferation of normal human dental pulp cells affected by different sizes of 
chitosan nanoparticles at different time intervals 
 
Figure 14 illustrates a comparison of the effects of 50 nm and 350 nm chitosan at 
different concentrations on the proliferation rate of normal human dental pulp cells after three 
days’ exposure. The results of this experiment suggest that both 50 nm and 350 nm, at doses 
of 0.5 mg/mL, 1 mg/mL, and 2 mg/mL, did not significantly influence the proliferation rate 
as compared to the control (P > 0.05). A nano-effect was noticed at a concentration of 4 
mg/mL, where 50 nm significantly reduced the proliferation rate compared to 350 nm (P < 























Figure 15 illustrates a comparison between the effects of 50 nm and 350 nm chitosan at 
different concentrations on the proliferation rate of normal human dental pulp cells after 
seven days’ exposure. At a concentration of 0.5 mg/mL, cells treated with both 50 nm and 
350 nm displayed a comparable proliferation rate as compared to the control group. As the 
concertation increased to 1 mg/mL, cells exposed to 50 nm showed a lower proliferation rate 
as compared to 350 nm and the control group; however, this difference was not statistically 
significant (P > 0.05). A nano-effect became more apparent with higher concentrations (2 
mg/mL and 4 mg/mL), where 50 nm significantly reduced the cell number in the culture plate 

























Figure 16 illustrates a comparison between the effects of 50 nm and 350 nm chitosan at 
different concentrations on the proliferation rate of normal human dental pulp cells after 14 
days’ exposure. After 14 days of exposure to chitosan nanoparticles, cells treated with both 
50 nm and 350 nm at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL 
displayed a significant reduction in proliferation rate in dose-dependent and size-associated 
manners when compared to the control group (P < 0.05). At each tested concentration, 50 nm 

























































2.4 Mitochondrial dehydrogenase enzyme activity 
 
2.4.1 Mitochondrial dehydrogenase enzyme activity in normal human dental pulp cells 
affected by different doses of 50 nm at different time intervals 
 
      The influence of 50 nm chitosan on the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells after three days’ exposure is illustrated in figure 17. It was 
noted that cells treated with all concentrations of 50 nm expressed a comparable activity of 
mitochondrial dehydrogenase enzyme activity as the control group (P > 0.05). This finding 
suggests that 50 nm chitosan at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 























Figure 17: Mitochondrial dehydrogenase enzyme activity in human dental pulp cells exposed 
to various concentrations of chitosan nanoparticles for three days  
Note: The data are presented as the means of four separate experiments with error bars 














































Mitochondrial dehydrogenase enzyme 
activity in hDPCs exposed to various 




The influence of 50 nm chitosan on the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells after three days’ exposure is illustrated in figure 18. After 
seven days of exposure, cells that were exposed to 0.5 mg/mL of 50 nm chitosan expressed 
comparable mitochondrial dehydrogenase enzyme activity as the control group (P < 0.05). 
When the concentration increased to 1 mg/mL, a reduction in mitochondrial dehydrogenase 
activity was noted; however, this reduction was not statistically significant (P > 0.05). Cells 
exposed to higher concentrations of 50 nm chitosan (2 mg/mL and 4 mg/mL) displayed 























 The influence of 50 nm chitosan on the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells after three days’ exposure is illustrated in figure 19. After 14 
days of exposure, all cells in nanoparticle-treated groups demonstrated significantly lower 
activity of mitochondrial dehydrogenase enzyme as compared to the control (P < 0.05). This 
reduction in the enzyme activity was observed to be in a dose-dependent manner. As the 
concentration increased from 0.5 mg/mL to 4 mg/mL, the enzyme activity decreased from 






















2.4.2 Mitochondrial dehydrogenase enzyme activity in normal human dental pulp cells 
affected by different doses of 350 nm at different time intervals 
 
The influence of 350 nm chitosan on the mitochondrial dehydrogenase enzyme activity 
of normal human dental pulp cells after three days of exposure is illustrated in figure 20. It 
was noted that cells treated with all concentrations of 350 nm expressed a comparable 
mitochondrial dehydrogenase enzyme activity as the control group (P > 0.05). This finding 
suggests that 350 nm chitosan at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 













Figure 20: Mitochondrial dehydrogenase enzyme activity in human dental pulp cells exposed 
to various concentrations of chitosan nanoparticles for three days  
Note: The data are presented as the means of four separate experiments with error bars 






















































Mitochondrial dehydrogenase enzyme 
activity in hDPCs exposed to various 





The influence of 350 nm chitosan on the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells after seven days’ exposure is illustrated in figure 21. It was 
noted that cells treated with all concentrations of 350 nm expressed a comparable 
mitochondrial dehydrogenase enzyme activity as the control group (P > 0.05). This finding 
suggests that 350 nm chitosan at concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 































Figure 21: Mitochondrial dehydrogenase enzyme activity in human dental pulp cells exposed 
to various concentrations of chitosan nanoparticles for seven days  
Note: The data are presented as the means of four separate experiments with error bars 
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The influence of 350 nm chitosan on the mitochondrial dehydrogenase enzyme activity of 
normal human dental pulp cells after 14 days’ exposure is illustrated in figure 22. The effect 
of 350 nm chitosan on the enzyme activity became more apparent after 14 days of exposure 
time. All cells treated with all concentrations of 350 nm expressed significantly lower 
enzyme activity as compared to the control group (P < 0.05). The reduction in the enzyme 
activity was significantly reduced as the concentration increased from 0.5 mg/mL to 4 mg/mL 
(P < 0.05). This reduction in mitochondrial enzyme activity appeared to be in a dose-























2.4.3 Mitochondrial dehydrogenase enzyme activity in normal human dental pulp cells 
affected by different sizes of chitosan nanoparticles at different time intervals 
 
   Figure 23 illustrates a comparison of the effects induced by various concentrations of 50 
nm chitosan versus various concentrations of 350 nm chitosan on the activity of 
mitochondrial dehydrogenase enzymes after three days’ exposure. The results indicate that 
the enzyme activity in cells treated with all nanoparticle concentrations and sizes was 
comparable to the control group (P > 0.05). Additionally, no significant difference was noted 























Figure 24 illustrates a comparison between the effects induced by various concentrations 
of 50 nm chitosan versus various concentrations of 350 nm chitosan on the activity of 
mitochondrial dehydrogenases enzyme after seven days’ exposure. At a lower concentration 
(0.5 mg/mL), the enzyme activity in cells exposed to 50 nm chitosan was comparable to those 
exposed to 350 nm chitosan (P > 0.05) and the control group (P > 0.05). At a concentration of 
1 mg/mL, it was noted that the enzyme activity reduced in cells exposed to 50 nm chitosan as 
compared to 350 nm chitosan and the control group; however, this reduction in enzyme 
activity was not statistically significant. At higher concentrations (2 mg/mL and 4 mg/mL), a 
nano-effect was more apparent as the enzyme activity was significantly lower in cells 






















Figure 25 illustrates a comparison of the effects induced by various concentrations of 50 
nm chitosan versus various concentrations of 350 nm chitosan on the activity of 
mitochondrial dehydrogenase enzymes after 14 days’ exposure. At this point in time, the 
nano-effect became more evident at all concentrations tested in the experiment. It was noted 
that cells showed a significantly lower enzyme activity in all nanoparticle-treated groups as 
compared to the control (P < 0.05). At each tested concentration, cells exposed to 50 nm 
chitosan expressed notably lower enzyme activity than cells exposed to 350 nm chitosan (P < 
0.05). Such a finding suggests that the cytotoxicity induced by chitosan nanoparticles on 


























































2.5 Phosphorylation of H2AX histones 
 
2.5.1 Phosphorylation of H2AX histones in normal human dental pulp cells cultured 
with different doses of 50 nm chitosan for 24 hours 
 
Figure 26 illustrates the phosphorylation of H2AX histones in normal human dental pulp 
cells exposed to 50 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. 
The findings of this experiment suggest that pH2AX was not detectable in cells exposed to 50 
nm chitosan at a concentration of 0.1 mg/mL. As the concertation increased to 0.5 mg/mL 
and 2 mg/mL, pH2AX histones were observed in significantly higher levels as compared to 
the control (P < 0.05). Additionally, the level of pH2AX histones was notably higher in the 2 






















2.5.2 Phosphorylation of H2AX histones in normal human dental pulp cells cultured 
with different doses of 350 nm chitosan for 24 hours 
 
Figure 27 illustrates the phosphorylation of H2AX histones in normal human dental pulp 
cells exposed to 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. 
The expression of pH2Ax histones in cells exposed to 350 nm was in an analogous pattern as 
that shown by cells exposed to 50 nm chitosan. The lower concentration, 0.1 mg/mL, did not 
significantly induce pH2AX histones in human dental pulp cells as compared to the control (p 
> 0.05) and other groups (P > 0.05). At higher concentrations (0.5 mg/mL and 2 mg/mL), the 
expression of pH2AX histones was evident when compared to the control group (p < 0.05). 
The level of pH2AX histones was significantly higher in cells exposed to 350 nm chitosan at 






















2.5.3 Phosphorylation of H2AX histones in normal human dental pulp cells cultured 
with different sizes of chitosan nanoparticles for 24 hours 
 
Figure 28 illustrates a comparison between the level of pH2AX histones in normal human 
dental pulp cells exposed to 50 nm and 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 
mg/mL, and 2 mg/mL. At a concentration of 0.1 mg/mL, both 50 nm and 350 nm chitosan 
did not induce significant levels of pH2AX histones when compared to the control group (p > 
0.05). A nano-effect was more evident at concentration of 0.5 mg/mL and 2 mg/mL, where 
50 nm chitosan induced significantly higher levels of pH2AX histones than 350 nm chitosan 






































Photo 10: The image from an epifluorescence microscope shows the formation of nuclear 

















































2.6 Cytokinesis block micronucleus assay 
 
2.6.1 Expression of micronuclei in normal human dental pulp cells cultured with 
different concentrations of 50 nm chitosan for 24 hours 
 
Figure 29 illustrates the level of micronuclei expressed by human dental pulp cells 
exposed to 50 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. Cells 
cultured with a lower concentration, 0.1 mg/mL, showed comparable levels of micronuclei as 
the control group (P > 0.05). When the concentration increased, the level of micronuclei was 
more evident. Cells cultured with concentrations of 0.5 mg/mL and 2 mg/mL expressed 
significantly higher levels of micronuclei when compared to the control (P < 0.05) and 0.1 






















2.6.2 Expression of micronuclei in normal human dental pulp cells cultured with 
different concentrations of 350 nm chitosan for 24 hours 
 
Figure 30 illustrates the levels of micronuclei expressed by human dental pulp cells 
exposed to 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. Cells 
cultured with different concentrations of 350 nm chitosan expressed micronuclei in a similar 
pattern as shown by cells exposed to 50 nm chitosan. At a lower concentration, 0.1 mg/mL, 
cells showed comparable levels of micronuclei as the control group (P > 0.05). When the 
concentration increased, the level of micronuclei was more evident. Cells cultured with 
concentrations of 0.5 mg/mL and 2 mg/mL expressed significantly higher levels of 
micronuclei than the control (P < 0.05) and 0.1 mg/mL (P < 0.05) groups, where the highest 






















2.6.3 Expression of micronuclei in normal human dental pulp cells cultured with 
different sizes of chitosan nanoparticles for 24 hours 
 
Figure 31 illustrates a comparison between the levels of micronuclei in normal human 
dental pulp cells exposed to 50 nm and 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 
mg/mL, and 2 mg/mL. At a concentration of 0.1 mg/mL, both 50 nm and 350 nm chitosan 
did not induce significant levels of micronuclei when compared to the control group (p > 
0.05). A nano-effect was more evident at concentrations of 0.5 mg/mL and 2 mg/mL, where 


























2.6.4 Expression of nuclear buds in normal human dental pulp cells cultured with 
different concentrations of 50 nm chitosan for 24 hours 
 
Figure 32 illustrates the levels of nuclear buds expressed by human dental pulp cells 
exposed to 50 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. Cells 
cultured with a lower concentration, 0.1 mg/mL, showed comparable levels of nuclear buds 
as the control group (P > 0.05). When the concentration of 50 nm chitosan increased, the 
level of nuclear buds was more evident. Cells cultured with concentrations of 0.5 mg/mL and 
2 mg/mL expressed significantly higher levels of nuclear buds than the control (P < 0.05) and 
























2.6.5 Expression of nuclear buds in normal human dental pulp cells cultured with 
different concentrations of 350 nm chitosan for 24 hours 
 
Figure 33 illustrates the levels of nuclear buds expressed by human dental pulp cells 
exposed to 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, and 2 mg/mL. Cells 
cultured with different concentrations of 350 nm chitosan expressed nuclear buds in a similar 
pattern as shown by cells exposed to 50 nm chitosan. At a lower concentration, 0.1 mg/mL, 
cells showed comparable levels of nuclear buds as the control group (P > 0.05). When the 
concentration of 350 nm chitosan increased, the level of nuclear buds was more evident. Cells 
cultured with concentrations of 0.5 mg/mL and 2 mg/mL expressed significantly higher 
levels of nuclear buds when compared to the control (P < 0.05) and 0.1 mg/mL (P < 0.05), 























2.6.6 Expression of nuclear buds in normal human dental pulp cells cultured with 
different sizes of chitosan nanoparticles for 24 hours 
 
Figure 34 illustrates a comparison between the levels of nuclear buds in normal human 
dental pulp cells exposed to 50 nm and 350 nm chitosan at concentrations of 0.1 mg/mL, 0.5 
mg/mL, and 2 mg/mL. At a concentration of 0.1 mg/mL, both 50 nm and 350 nm chitosan 
did not induce significant levels of nuclear buds when compared to the control group (p > 
0.05). A nano-effect was more evident at concentrations of 0.5 mg/mL and 2 mg/mL, where 

















































2.7 Cellular uptake 
 
2.7.1 Uptake of various concentrations of 50 nm chitosan by normal human dental pulp 
cells cultured after 24 hours 
 
Figure 35 illustrates the human dental pulp cells’ uptake of various concentrations of 50 
nm chitosan after 24-hour exposure time. At a lower concentration, 0.1 mg/mL, 50 nm 
chitosan was not significantly internalized in human dental pulp cells (P > 0.05). When the 
concentration was increased to 0.5 mg/mL and 2 mg/mL, a cellular uptake of 50 nm chitosan 
was evident as compared to the control group (P < 0.05). Additionally, 50 nm chitosan at a 
concentration of 2 mg/mL was significantly engulfed by human dental pulp cells, more than 























2.7.2 Uptake of various concentrations of 350 nm chitosan by normal human dental 
pulp cells cultured after 24 hours 
 
Figure 36 illustrates the human dental pulp cells’ uptake of various concentrations of 
350 nm chitosan after 24-hour exposure time. Human dental pulp cells uptake 350 nm 
chitosan in a similar pattern as seen with 50 nm chitosan. At a lower concentration, 0.1 
mg/mL, 350 nm chitosan was not significantly internalized in human dental pulp cells (P > 
0.05). When the concentration was increased to 0.5 mg/mL and 2 mg/mL, the cellular uptake 
of 350 nm chitosan was evident as compared to the control group (P < 0.05). Additionally, 
350 nm chitosan at a concentration of 2 mg/mL was significantly engulfed by human dental 























2.7.3 Uptake of various sizes of chitosan nanoparticles by normal human dental pulp 
cells cultured after 24 hours 
 
Figure 37 illustrates a comparison between cellular uptake of various concentrations of 
50 nm chitosan versus various concentrations of 350 nm chitosan by the human dental pulp 
cells after 24-hour exposure time. At a lower concentration, 0.1 mg/mL, both 50 nm chitosan 
and 350 nm chitosan did not significantly internalize the human dental pulp cells when 
compared to the control (P > 0.05). When the concentration was increased to 0.5 mg/mL and 
2 mg/mL, a nano-effect was evident as the cellular uptake of 50 nm chitosan was 


























































Chapter 6: Discussion 
 
      The inherent antimicrobial property of chitosan nanoparticles has attracted much 
attention, especially in endodontic and preventive dentistry fields. Studies have shown that 
chitosan nanoparticles can significantly reduce the biofilms of E. faecalis and Streptococcus 
mutans, bacteria associated with periapical infections and dental caries, respectively (98, 
120). Another recent study has demonstrated that photoactivated rose Bengal chitosan 
nanoparticles can significantly disinfect LPS-contaminated root canals (121). This 
antimicrobial property has been exploited by researchers to improve the antibacterial activity 
of several dental materials such as zinc oxide-eugenol sealer, epoxy resin sealer, calcium 
hydroxide medicament, and composite restoration (98, 102, 106, 122). Moreover, it has been 
reported that modified chitosan nanoparticles could serve as a promising, indirect dental pulp 
capping material as chitosan plays a role in the remineralization of a demineralized dentin in 
a deep caries tooth model (123).  
In parallel with the antibacterial studies, others have raised concerns about the 
biocompatibility of chitosan nanoparticles on normal cell cultures. It is imperative to evaluate 
the potential toxicity of these nanoparticles on a cell culture that is more relevant to the dental 
clinical situation. Although numerous studies have discussed the properties of chitosan 
nanoparticles as a promising polymer in the field of dentistry, there is limited knowledge 
regarding chitosan biocompatibility with normal human dental pulp cells. To the best of the 
author’s knowledge, this is the first report that has evaluated the potential toxicity of various 
sizes and concentrations of chitosan nanoparticles on dental pulp cells derived from healthy 
humans. Due to the possible interaction between the nanoparticles and dental pulp in some 
clinical applications, it is becoming a pressing issue to determine the most appropriate 
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concentration and size of chitosan nanoparticles to be utilized without causing any toxicity to 
the dental pulp. 
       The chosen concentrations in the present study were either similar to or lower than the 
concentrations tested in the previous antimicrobial studies. Antimicrobial studies have 
indicated that chitosan nanoparticles in concentrations of 2 mg/mL, 5 mg/mL, and 10 mg/mL 
could effectively kill E. faecalis bacteria (99). Another report, published by Arancibia et al., 
has presented that only at a concentration of 5 mg/mL were chitosan nanoparticles efficacious 
in suppressing the growth of aggregatibacter actinomycetemcomitans and porphyromonas 
gingivalis, the bacteria associated with periodontal diseases (124). Likewise, the growth of 
the cariogenic streptococci was significantly downregulated after exposure to chitosan 
nanoparticles in concentrations of 1.25 mg/mL, 2 mg/mL, and 5 mg/mL (75). In addition, the 
anticandidal property of chitosan nanoparticles has been reported by Ing et al. In that study, it 
was shown that the minimum inhibitory concentration of chitosan nanoparticles to reduce the 
growth of 90% of Candida albicans was 0.2 mg/mL (125).  
The findings of the present study suggest that chitosan nanoparticles in concentrations 
of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL induced a cytotoxic effect on normal 
human dental pulp cells in dose-dependent and size-associated manners. The cytotoxicity of 
chitosan nanoparticles was previously observed on animal models. In Park et al.’s study, 100 
nm chitosan nanoparticles showed an inhibitory antiproliferative effect on embryonic mice 
cells in a dose-dependent manner. In that study, there was an upregulation in apoptotic 
proteins such as Bad and Bax as the concentrations of the chitosan nanoparticles increased 
from 0.01 mg/mL to 0.2 mg/mL (12). Another study, conducted on a zebrafish model 
exposed to 250 nm chitosan nanoparticles, has shown variable mortality rates with different 
concentrations. Nearly a 100% mortality rate was achieved with a concentration of 0.05 
mg/mL, while a lower than 20% mortality rate was noted with a concentration of 0.005 
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mg/mL (13). Furthermore, another paper by Almalik et al. has illustrated the significant 
release of lactate dehydrogenase enzyme, production of reactive oxygen species, and 
reduction in cell viability in Chinese hamsters’ ovary cell culture exposed to 222 nm CS 
nanoparticles at a dose of 2.5 mg/mL for 24 h (14). 
       Another critical aspect of the present study is the comparison among the effects of 
different particles sizes. To accurately assess the nano-effects of chitosan, it was crucial to 
control the particle size in the culture medium. The terms “aggregation” and “agglomeration” 
are distinctly different, yet they have been commonly used interchangeably. Aggregation is 
an indication of a strong bonding between the particles, while agglomeration is an indication 
of a weak particle bonding. Throughout this thesis, the term “agglomeration” was used as not 
enough energy had been applied in the present project to induce particles’ aggregation. Most 
types of nanoparticles tend to agglomerate quickly in physiological solutions. It was reported 
that gold, silver, cerium oxide, and amine-modified polystyrene nanoparticles all agglomerate 
significantly from a small number of nanometers up to hundreds of nanometers within 10 
minutes after suspension in DMEM culture medium (126).  
In a complex biological solution, suspended nanoparticles are normally confronted 
with several forces. Whenever the exerted van-der-Waals forces on nanoparticles exceeds the 
repulsive electrostatic force, the nanoparticles tend to agglomerate (127). Furthermore, 
nanoparticles’ surface charge (128), concentration (129), size (130), structure (131), chemical 
composition (6), and organic constituents in a culture medium (127) appeared to be factors 
contributing to the formation of large agglomerates. The cationcity of chitosan nanoparticles, 
which is owed to the presence of active amino groups in chitosan`s composition, could 
manipulate the agglomeration of the particles. As the cationcity increases, the electrostatic 
repulsive forces among the nanoparticles increases, which consequently reduces the 
agglomeration. Concentration of nanoparticles in the culture medium is another factor that 
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plays a decisive role in governing the stability of nanoparticles. It was reported that titanium 
dioxide nanoparticles significantly agglomerated from 793 nm up to 2833 nm in an RPMI 
culture medium as the concentration increased from 0.005 mg/mL to 0.05 mg/mL (129).  
       This increase in agglomeration was associated with nanoparticles’ sedimentation (129). 
Ideally, the nanoparticles should be well dispersed in the culture medium to ensure equal 
numbers of nanoparticles interacting with the cell surface. Nanoparticles’ agglomeration and, 
later on, sedimentation because of the gravity force will vary the concentration of 
nanoparticles on the cell surface, which would mislead the toxicity assessment accordingly 
(132). Moreover, particle size has been known to influence the stability of nanoparticles. A 
study published by Kawata et al has shown that silver nanoparticles smaller than 50 nm 
exhibited a high agglomeration state as compared to larger nanoparticles (2).  
        Formation of micro-meter large agglomerates in culture media creates a challenging 
issue as this could complicate the researcher’s ability to deduce the nanoparticles’ interaction 
with living cells. It was shown that the formation of larger agglomerates of silver 
nanoparticles significantly reduced the hemolytic toxicity that was observed in these 
nanoparticles (126). Several methods have been proposed in the literature to minimize the 
agglomeration issue. Herein, during the nanoparticles’ preparation, it was noted that the 
agglomeration was significantly lower when nanoparticles were suspended in water as 
compared to the culture medium. Furthermore, the agglomeration of nanoparticles was 
dramatically reduced in media supplemented with fetal bovine serum as compared to media 
that lacks this protein. Other reports shared comparable findings with various kinds of 
nanoparticles (133–135). The stability of nanoparticles in water can be referred to the 
hydrophilic repulsion created by water molecules, which, under adequate energy, bind to the 
surface of the nanoparticles and establish a steric bumper layer (136). This layer prevents any 
pair of nanoparticles to be bound together, therefore enhancing the stability of the suspended 
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nanoparticles (136). Additionally, the role of fetal serum in decreasing nanoparticles’ 
agglomeration might be due to the protein adsorption onto the nanoparticles’ surface, which 
consequently generates an electrostatic repulsive force faster than the formation of 
agglomeration (127).  
Moreover, the findings by Zook et al. suggest that the addition of the bovine serum 
albumin was beneficial to keep the stability of the nanoparticles for three days (126). In the 
present study, although culture medium proteins reduced the agglomeration of nanoparticles, 
the sizes of the nanoparticles were not controlled completely, as indicated by DLS, which 
showed that there was still a significant agglomeration. Therefore, in addition to the 
electrostatic repulsion created by FBS, all nanoparticle-supplemented culture media were 
subjected to sonication agitation to preserve the stability of nanoparticles’ sizes throughout 
the whole period of time for the experiments. The latter finding opposes the results reported 
by Murdock et al., who found that ultrasonic cavitation exhibits no significant effect on 
reducing the agglomeration of silver nanoparticles (135). This difference in the reported 
findings might be attributed to the sonication time and nanoparticle type. In the latter study, 
the researchers subjected the nanoparticles to sonication cavitation for only 60 seconds, 
unlike in the present study, where chitosan nanoparticles were sonicated for a longer time, up 
to five minutes. Nevertheless, other studies have further confirmed that ultrasound cavitation 
can disintegrate the large agglomerates effectively, as reported in numerous publications 
(137). The colloidal stability was also ensured by visually inspecting the nanoparticle-
supplemented culture media after the sonication treatment, which revealed an absence of 
sedimentation. 
 Using a transmission electron microscope for assessing the characterization of the 
nanoparticles is not completely accurate as, in this method, the nanoparticles are being 
investigated in a dried form. Therefore, in the present study, the TEM assessment was 
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accompanied by dynamic light scattering evaluation, which is a well-known, reliable 
technique for analyzing the particles’ size distributions (138). Prior to cytotoxicity and 
genotoxicity evaluation, nanoparticles’ mean size, size distribution, surface charges, and 
polydispersity were further confirmed using dynamic light scattering. 
       There was limited knowledge regarding the nanotoxicity induced by different sizes of 
chitosan nanoparticles; however, this size-dependent nanotoxicity was observed with other 
types of nanoparticles, such as silica and hydroxyapatite nanoparticles, cultured with different 
cell populations. The findings reported by Xu et al. have shown that 20 nm silica 
nanoparticles induced higher cytotoxicity on human lung fibroblasts in comparison to 80 nm 
at each concentration used in that study (10). Furthermore, an analogous effect was reported 
with hydroxyapatite nanoparticles cultured with human hepatoma HepG2 cells. In that study, 
human hepatoma cells underwent a size-dependent cytotoxicity and apoptosis (139). This 
size-associated nanotoxicity is probably due to the fact that smaller nanoparticles are more 
susceptible to cellular uptake when compared with larger nanoparticles. However, the 
viability of SCAP cells was not affected when the cells were cultured with 0.3 mg/mL 
chitosan nanoparticles for 24 h (108). Another study has suggested that 0.6 mg/mL CS 
nanoparticles displayed no significant alteration on the viability of the human gingival 
fibroblasts after 72 h culture time (140). In that study, concentrations of 0.1 mg/mL and 0.3 
mg/mL exhibited a proliferative effect on the human gingival fibroblasts within 72 h (140). 
These opposite findings might primarily be the result of the short exposure time. In the 
present study, it was observed that low concentrations such as 0.5 mg/mL required two weeks 
to induce a cytotoxic effect on the human dental pulp cells, which underlines the importance 
of a prolonged culture time in cytotoxicity assessment.  
       It is well known that the chitosan nanoparticles obtain a positive charge due to the 
presence of active amino groups within their composition (25). The potential toxicity induced 
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by chitosan nanoparticles might be due to an electrostatic interaction between the cationic 
chitosan nanoparticles and the negatively charged cellular membrane (29). The small size of 
chitosan nanoparticles probably allowed nanoparticles to penetrate the cellular membrane 
and, consequently, led to cellular death. In a study where the liver cells were exposed to 
chitosan nanoparticles, transmission electron microscopy images revealed that these 
nanoparticles can internalize the cells and deteriorate the nuclear membrane readily (141). 
However, further investigations are still needed to clearly understand the molecular pathways 
behind the toxicity induced by chitosan nanoparticles. 
        Moreover, the cellular uptake of different sizes and concentrations of chitosan 
nanoparticles was tested by tagging the nanoparticles with FITC fluorescent stain. This 
tagging process is based on the covalent bond that forms between active amino groups in 
chitosan with the isothiocyanate group in FITC, which has been shown to resist the 
photobleaching effect more than the pure FITC stain (118). The FITC tagging method 
demonstrated that the 50 nm nanoparticles were engulfed by pulp cells more than 350 nm at 
all tested concentrations. This can be explained by the fact that smaller nanoparticles have 
more ability to penetrate the cellular membrane than larger nanoparticles. Furthermore, there 
was a dose-dependent response in both size groups. This method was also used, with similar 
findings, by Huang et al., who demonstrated the cellular internalization of chitosan 
nanoparticles in epithelial cells (142). Concentration-dependent uptake of chitosan 
nanoparticles might be due to the fact that the zeta-potential is decreased if the nanoparticle 
solution is diluted, which consequently reduces interaction between the positively charged 
nanoparticles and the negatively charged cellular membrane. 
         In addition, DNA damage, which could be a potential cause for cellular death, was 
assessed as early as 24 hours from exposure to chitosan nanoparticles. The DNA damage in 
the present study was assessed by quantifying the frequencies of micronuclei, nuclear buds, 
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and phosphorylated H2AX histones, which are recognized indications for DNA double-
strands breaks (117, 143). Micronuclei formation is a sign of chromosomal fragments that are 
left behind during anaphase nuclear division (117). Nuclear bud formation is a sign of DNA 
amplification at the site of the nuclear damage that is being eliminated from the nucleus 
(117). Only by blocking cell division using agents such as cytochalasin-b can chromosomal 
abnormality be detected microscopically by a specific stain that has a high affinity to DNA, 
such as DAPI stain (117). Moreover, when DNA double-strand breaks occur, a 
phosphorylation of a specific site on H2AX histone will occur to recruit the repairing proteins 
(144). Using antibodies conjugated with florescent stain that specifically binds to the 
phosphorylated H2AX, areas of DNA double-strand breaks can be accurately detected (144).  
There is evidence that these chromosomal abnormalities can potentially be transferred 
to the offspring cells during proliferation (145). An experiment was done by Lodish et al. 
(2000) where DNA was extracted from tumor cells and cultured with normal mouse 
fibroblasts, which normally grow as a monolayer because the normal fibroblasts stop dividing 
when they come in contact with other cells (145). It was shown that some of the normal 
fibroblasts took up the mutated DNA and transformed into tumor cells by rapidly 
proliferating and forming a pile of cells in the culture dish (145). In the present study, it was 
demonstrated that when the load concentration of chitosan nanoparticles increased to 0.5 
mg/mL and 2 mg/mL, cellular uptake and DNA damage were observed in human dental pulp 
cells in dose-dependent and size-associated manners. Such a finding is imperative in a 
clinical situation as it implies that the amount of chitosan nanoparticles leaching out of the 
dental material should not exceed 0.5 mg/mL to avoid genotoxicity on the dental pulp.  
        The DNA-damage effect of chitosan nanoparticles on human dental pulp cells was not 
reported previously in the literature. Nevertheless, genotoxicity of different types of 
nanoparticles has been previously described in the literature on cells that are sensitive in 
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microenvironments. A study conducted by Chou et al. has shown that the micronuclei were 
expressed in high quantity by cervical cancer cells (Hela cells) after exposure to several 
concentrations of silver nanoparticles suspended in hydrogel (3). Another report has also 
suggested an analogous size-dependent genotoxic effect induced by silica nanoparticles 
cultured with human umbilical vein endothelial cells (146). 
        Finally, another key finding presented in this paper is the limited uptake and the absence 
of genotoxicity of chitosan nanoparticles at a concentration of 0.1 mg/mL on human dental 
pulp cells. As mentioned previously, antibacterial studies utilized chitosan nanoparticles at 
doses higher than 0.1 mg/mL. A report by Arancibia et al. has presented that only at a 
concentration of 5 mg/mL were chitosan nanoparticles efficacious in suppressing the growth 
of aggregatibacter actinomycetemcomitans and porphyromonas gingivitis, the bacteria 
associated with periodontal diseases (124). Likewise, the findings of Alisghari et al. have 
indicated that the minimum inhibition concentration of chitosan nanoparticles against 
cariogenic S. mutans, S. sobrinus, and S. salivarius was found to be at 0.6 mg/mL with 
minimum bacterial concentration observed with at least 1.2 mg/mL and 2.5 mg/mL 
concentrations (75). Nevertheless, studies have shown that the antimicrobial activity of 
chitosan nanoparticles at a dose of 0.1 mg/mL can be boosted by alternative methods such as 













































Chapter 7: Conclusion 
 
It was concluded that chitosan nanoparticles at sizes 50 to 67 nm and 318 to 350 nm and 
concentrations of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL were able to penetrate the 
cellular membrane of human dental pulp cells and induced cytotoxic and genotoxic effects 
after 14 days’ exposure time in a dose-dependent and size-associated manner. At all tested 
concentrations, group 50 to 67 nm significantly showed higher cytotoxicity and genotoxicity 
on hDPCs when compared to group 318 to 350 nm. This is the first report to demonstrate the 
influence of various sizes and concentrations of chitosan nanoparticles on the attachment 
efficiency, proliferation rate, mitochondrial dehydrogenase enzyme activity, cellular uptake, 
expression of phosphorylated H2AX histones, and formation of chromosomal abnormality 
such as micronuclei and nuclear buds on normal human dental pulp cells. The findings of the 
present project will lead to a better understanding of the biocompatibility of chitosan 











7.1 Clinical considerations 
        Because of the known toxicity induced by metallic and inorganic nanoparticles, the focus 
has been shifted to utilize organic nanoparticles such as chitosan. In endodontics, chitosan 
nanoparticles were tested in different applications to exploit chitosan’s antibacterial property 
and encapsulation ability. Due to the complexity of the root canal system and the ability of 
certain types of bacteria to survive at the deepest portion of the canal, constant efforts have 
been made to improve the antibacterial activity of endodontic materials. It was shown that the 
antibacterial activity of some endodontic sealers, intracanal medicament, and irrigation 
solutions were sufficiently enhanced after incorporation with chitosan nanoparticles. In 
addition, chitosan nanoparticles were employed in regenerative endodontic applications. 
Some bioactive molecules that help in SCAP cells’ differentiation lose their concentrations 
over time. Studies have shown that encapsulation of bioactive molecules into chitosan 
nanoparticles can provide a controlled release over time due to the slow degradability of 
chitosan nanoparticles. This makes the bioactive molecules readily available at optimum 
concentrations for SCAP cells to aid the differentiation process.  
In some applications, there is a possible communication between chitosan 
nanoparticles and dental pulp tissue. Several studies have utilized chitosan nanoparticles as 
anticariogenic and antibacterial agents against cariogenic and periodontal pathogens. 
Moreover, chitosan nanoparticles were proven to enhance the structure of dentin collagen 
matrix and promote remineralization of demineralized enamel. In the latter applications, 
chitosan nanoparticles come in close contact with dental pulp through the passages via 
dentinal tubules. Therefore, it is becoming a necessity to evaluate the biocompatibility of 
various sizes and concentrations of chitosan nanoparticles on dental pulp cells. This 
evaluation might help in determining the most appropriate sizes and concentration to be used 
without causing any harmful effect on dental pulp.  
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The present study evaluated the effect of 50 to 67 nm chitosan and 318 to 350 nm 
chitosan at concentrations of 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/mL on 
attachment efficiency, proliferation rate, mitochondrial dehydrogenase enzyme activity, 
cellular uptake, expression of chromosomal abnormalities, and formation of pH2AX histones 
on dental pulp tissues. It was noted that chitosan nanoparticles induced a significant cytotoxic 
and genotoxic effect after 14 days’ exposure time. Such findings may aid in the 
understanding of the cellular behavior that would arise from the use of chitosan particles, 
which will consequently lead to better applications of chitosan nanoparticles in the 














7.2 Limitations and future studies 
 
 
This in vitro study showed that 50 to 67 nm and 318 to 350 nm chitosan can penetrate the 
cellular membrane of human dental pulp cells, reducing cell attachment, proliferation rate, 
and mitochondrial dehydrogenase activity and increasing the formation of chromosomal 
anomalies and expression of phosphorylated H2AX histones. However, further study must be 
conducted to fully understand the mechanisms of cytotoxicity and genotoxicity induced by 
chitosan nanoparticles at the cellular and molecular levels.  
In addition, in the present study, only chitosan with a medium molecular weight and 85% 
degree of deacetylation was tested. Future evaluations of biocompatibility of chitosan with 
lower molecular weights and higher degrees of deacetylation should be conducted as these 
factors affect the chitosan surface charges and consequently influence the interaction between 
the nanoparticles and cellular membrane.  
Moreover, the information obtained from this in vitro study is limited. Therefore, in vivo 
studies on animals are required to assess the ability of the immune system and inflammatory 
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